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Abstract 
Borrelia spirochetes are the causative agents of Lyme disease and relapsing fever, two 
common vector-borne diseases.  Early experimental evidence, gained from development of 
genetic tools in the Lyme disease spirochete, Borrelia burgdorferi, emphasized the importance of 
outer surface lipo-proteins (Osps) during the infectious cycle.  Although the functions of these 
lipoproteins and the complex mechanism of differential regulation is known in increasing detail, 
it remains to be understood how these virulence factors reach the spirochetal surface.  We 
observed in previous studies that monomeric red fluorescent protein 1 (mRFP1) fused to 
specifically mutated outer surface protein A (OspA) lipopeptides could be detected by 
epifluorescence microscopy in both the periplasm and on the bacterial surface.  These findings 
supported the notion that Borrelia spirochetes do not adhere to the +2/+3/+4 sorting rules 
established in other eubacteria.  Rather, borrelial lipoproteins seem to contain a disordered 
‘tether’ peptide located at the extreme N-terminus of the mature lipoprotein that influences 
sorting within the envelope.  One facet of this study utilized an N-proximal tandem negative 
charge (Glu-Asp) that served as an inner membrane retention signal in OspA20:mRFP1 as a 
target for mutagenesis.  A library of random mutants in the two codons was generated and 
expressed in B. burgdorferi.  In situ surface proteolysis combined with fluorescence activated 
cell sorting (FACS) was then used to screen for viable spirochetes expressing subsurface 
OspA:mRFP1 fusions.  We successfully recovered several mutants that mislocalized the lipo-
mRFP1 fusions to the periplasm, adding to our database of peptide sequences that are not 
permissive for surface export.  We then broadened our studies to include the structurally and 
functionally distinct dimeric OspC-Vsp family lipoproteins and identified their requirements for 
surface localization.  As for OspA, tether sequences influence the localization of OspC-Vsp 
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lipoproteins within the envelope.  Interestingly, OspC-Vsp lipoproteins appear to be translocated 
across the outer membrane as monomers.  This suggests that they assume their final oligomeric 
state only when reaching the spirochetal surface.  Additionally, lower molecular weight variants 
of OspC and Vsp1 were detected indicating cleavage that was exacerbated upon addition of C-
terminal epitope tags or mislocalization of the untagged proteins to the periplasm.  C-terminal 
proteolysis of OspC was attributed to a carboxy-terminal protease, CtpA.  To date, known 
substrates of CtpA include the 13-kDa outer membrane porin, P13, and a periplasmic lipoprotein 
BB0323.  C-terminal proteolysis of OspC and Vsp1 suggests CtpA may also function as a 
periplasmic housekeeping protease.  In turn, released C-terminal peptides may play a role in 
initiation of an envelope stress response.  Another aspect of this work examined the subcellular 
localization pattern of Braun’s lipoprotein (Lpp) from E. coli using B. burgdorferi as a surrogate 
expression host.  Surprisingly, Lpp was localized to the B. burgdorferi inner membrane.  On the 
other hand, B. burgdorferi OspA mutants were sorted by E. coli according to E. coli rules.  This 
dataset confirmed that host factors are setting the rules for localization of lipoproteins within the 
bacterial envelope.  Taken together, this work revealed several factors, such as the composition 
of the lipoprotein tether and the folding state of the lipoprotein, which influences trafficking 
within the spirochetal cell envelope, and also provided important insights into periplasmic 
lipoprotein processing of B. burgdorferi.  These findings will broaden our understanding of 
spirochetal lipoprotein transport as well as cell envelope biogenesis.  Ultimately, this work may 
lead to novel treatments and/or vaccination strategies that will be extremely helpful in combating 
Lyme disease and relapsing fever in the years and decades to come. 
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Borrelia spirochetes are the causative agents of Lyme disease (LD), tick borne relapsing fever 
(TBRF) and louse borne relapsing fever (LBRF).  Lyme disease is the most common vector 
borne disease in North America, while TBRF is endemic to Africa.  Lyme disease was first 
described in 1977, when an outbreak of arthritis in children was centered around the town of Old 
Lyme, Connecticut (Steere et al., 1977), although documentation of LD symptoms date back to 
the late 19th century (Azfelius, 1910; Lipschutz, 1918).  Further investigation revealed the 
causative agent of LD was a spirochete, Borrelia burgdorferi (Burgdorfer et al., 1982), and was 
transmitted by Ixodes scapularis hard ticks (Steere et al., 1983; Benach et al., 1983).  The first 
description of TBRF dates back to the late 18th century and it was later determined transmission 
occurs via Ornithodoros soft ticks (Cutler, 2010; Southern and Sanford, 1969; Dworkin et al., 
2008).  ‘Relapsing fever’ was the name first ascribed to the disease following an outbreak in 
Edinburgh, United Kingdom in the 1840’s (Cutler, 2010). 
Surface lipoproteins play essential roles in maintaining the tick-mammalian infectious 
cycle in both diseases.  Tick midgut adhesins, immune evasion, and mammalian extra-cellular 
matrix (ECM) binding proteins are just a few of the functions of surface lipoproteins in Borrelia 
spirochetes.  Although an increasing amount is known about the regulation of lipoprotein-coding 
genes and the functions of the lipoproteins themselves, the basic question of how lipoproteins are 
localized to the bacterial surface remains elusive.  Answering this question is the main focus of 
our laboratory and the thrust of this dissertation.  The answer is far from simple, as more 
research needs to be completed to unlock the mystery of lipoprotein sorting in Borrelia.  It is my 
hope that the contributions of my graduate research will help elucidate decisive rules for 
lipoprotein sorting in Borrelia.   
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Lyme disease 
In 2009 there were ~30,000 cases of LD reported to the Centers for Disease Control and 
Prevention (CDC) with an additional 8,500 probable cases.  This represents an increase from 
~20,000 in 2006 (Bacon et al., 2008; CDC, 2010).  In the United States, LD is most commonly 
found in the northeast and north-central portions of the country.  However, cases have been 
reported in all 50 states (Bacon et al., 2008).  Borrelia burgdorferi senso stricto is the most 
common species of Borrelia that causes LD in North America (Baranton et al., 1992), while B. 
garinii and B. afzelii are largely responsible for LD in Europe and Asia (Bunikis et al., 2004; 
Stanek and Strle, 2009; Stanek et al., 2011).  With an increasing Ixodes scapularis tick 
population and continued urban sprawl, exposure of human populations to LD has risen 
significantly.  Ticks can acquire and transmit B. burgdorferi at any point in their life cycle, but 
most acquire the spirochetes in the larval stage from feeding on small rodents or birds, which are 
the natural reservoir (Mather et al., 1989; Donahue et al., 1987).  The larvae then molt to nymphs 
(Fig 1.1B) the following spring and feed on larger mammals.  The nymphs mature to adults over 
the course of the warm season and mate.  Eggs are laid in the fall and hatch the following spring, 
thus completing the life cycle (Bosler et al., 1983; Lane et al., 1991; Anderson, 1989; Matuschka 
et al., 1992; Schwan et al., 1988).   
Human infection commonly occurs during the late spring and summer when outdoor 
activity is frequent.  Ticks are hard to detect due to their small size, and most people do not 
remember being bitten.  Ixodes ticks take long blood meals (36-48 hours) that are essential for 
transmission of B. burgdorferi to the mammalian host (Piesman et al., 1987).  LD can be treated 
with a course of antibiotics.  Doxycycline is the drug of choice, with amoxicillin, cefuroxime 
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axetil, and erythromycin as alternatives (Wormser et al., 2006).  If left untreated, LD can lead to 
a serious multisystem disease.   
 LD is divided into three stages: i) early localized stage, ii) early disseminated, and iii) late 
persistent.  In the early-localized stage, the tick has finished feeding and detaches from the host.  
A ‘bullseye’ type rash called Erythema migrans (EM) usually appears at the site of the bite 
within several days (Fig. 1.1C).  The rash grows over time and can increase to 13 cm in diameter.  
During this stage, the person experiences flu-like symptoms i.e., fever, headache, malaise and 
muscle aches.  A few days later the early-disseminated stage begins when the spirochetes spread 
hematogenously. Spirochetes can be found in the joints, heart, brain, peripheral nervous system, 
and skin.  Secondary lesions resembling EM can appear on sites throughout the body, but are 
unrelated to the tick bite.  Neurological symptoms can also occur in 10-15% of untreated 
persons, the most common being Bell’s Palsy (Wormser et al., 2006).  If left untreated, late 
disseminated symptoms appear after several months.  Arthritis is the most common symptom and 
usually affects the knees, but can affect other joints as well.  About 60% of untreated persons 
develop arthritis, with children more prone than adults (Steere et al., 1987).  Neurologic and 
cardiac symptoms can also occur at this stage as the spirochetes can invade the peripheral and 
central nervous systems, with 5% of untreated patients experiencing a condition called 
neuroborreliosis (Reik et al., 1979; Pachner et al., 1984; Logigian et al., 1990; Pachner and 
Steiner, 2007).  
The immune response to Borrelia infection is a double-edged sword.  It works to 
eliminate the spirochetes, but is responsible for inflammation and tissue pathology associated 
with the disease (Salazar et al., 2003; Hirschfeld et al., 1999).  Binding and stabilization of 
plasmin on the surface of Borrelia leads to activation of host matrix-metalloproteinases (MMPs), 
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which contributes to inflammation and hematogenous spread (Gebbia et al., 2001; Gebbia et al., 
2004; Coleman et al., 1995; Coleman et al., 1999; Hu et al., 2001).  Toll-like receptor (TLR) 2 is 
also an important mediator of inflammation that specifically recognizes bacterial lipoproteins 
(Brightbill et al., 1999).  Heterodimerization with TLR1 leads to specific recognition of 
triacylated lipoproteins (Gram-negative bacteria) while heterodimerization with TLR6 
specifically recognized diacylated lipoproteins (Gram-positive bacteria) (Takeuchi et al., 2002; 
Kang et al., 2009; Schenk et al., 2009).  TLR2 activation via borrelial lipoproteins induces 
production of the pro-inflammatory cytokines TNF-α IL-1, IL-6 and CXCL-1 (Hirschfeld et al., 
1999).  Contrary to the implication of TLR2 in inflammation, studies in TLR2 and MyD88 
(adapter molecule in TLR signaling) knockout mice have shown an increased bacterial load and 
an increased inflammation when compared to wild type mice (Wooten et al., 2002; Liu et al., 
2004; Bolz et al., 2004; Behera et al., 2006; Benhnia et al., 2005).  This suggests other mediators 
of inflammation are also important during infection. 
B. burgdorferi has evolved mechanisms to persist within infected hosts for several 
months, or even years, by avoiding clearance by the immune system.  The three main 
mechanisms utilized for immune evasion are antigenic variation, down-regulation of a major 
surface protein, and binding of host complement factor H.  Antigenic variation by the surface 
lipoprotein VlsE (Vmp-like sequence) occurs at a 10-kb locus on one of the 28 kb linear 
plasmids (lp28-1) (vls) and 15 silent gene cassettes (vls2-16) (Zhang et al., 1997).  
Recombination between the expression site, located downstream of the promoter, and the silent 
cassettes can occur in as little as four days post infection.  No sequence variation was detected in 
strains that were cultured in vitro, suggesting that mammalian factors drive vlsE recombination 
(Zhang and Norris, 1998).  B. burgdorferi also binds complement factor H, factor H-like protein 
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1, and/or factor H-related protein, thus resisting attack by the complement system (Kraiczy et al., 
2001a; Kraiczy et al., 2001b; Brooks et al., 2005).  Outer surface lipoprotein C (OspC, which 
will be discussed in detail later) is a major surface lipoprotein upregulated during tick feeding, 
and is required to establish infection (Grimm et al., 2004).  In murine infection, ospC transcripts 
are undetectable 2 weeks post infection and anti-OspC antibodies synthesized during this time 
select for spirochetes that do not produce OspC (Liang et al., 2002).  In fact, Borrelia cells that 
constitutively synthesize OspC are rapidly cleared by the immune system, as OspC stimulates an 
effective humoral immune response (Xu et al., 2006). Thus, down regulation of OspC is essential 
for persistent infection.  With all the mechanisms B. burgdorferi employs to evade the immune 
system and persist within infected hosts for extended periods of time, what is the most effective 
method to prevent infection?  
 
Lyme Disease Vaccination 
As cases of LD continue to rise prevention of LD via vaccination is an attractive strategy.  Other 
measures such as protective clothing and routine use of tick repellents are ineffective in 
prevention of LD (Vázquez et al., 2008).  These findings, along with the high cost of diagnosis 
and duration (3-4 weeks) of antibiotic required for treatment make vaccination of high-risk 
individuals a logical and effective alternative.  Currently, no vaccine for LD is available for use 
in humans as LYMErix (discussed below) was pulled from the market in 2002.  Potential vaccine 
candidates and new strategies will be discussed below.  
To date, LYMErix is the first and only vaccine against B. burgdorferi licensed for use in 
humans.  It was approved by the FDA in 1997 and was manufactured by GlaxoSmithKline 
(GSK) (Van Hoecke et al., 1996).  LYMErix consists of recombinant OspA (a major surface 
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lipoprotein) from the ZS7 strain of B. burgdorferi that was synthesized in E. coli strain AR58 
without the lipid moiety.  After translation, the lipid was covalently bonded to the N-terminus 
and absorbed on an aluminum salt adjuvant.  The vaccine was buffered with phosphate buffered 
saline and phenoxy-ethanol was used as a preservative (Steere et al., 1998; Wormser, 1996).  
LYMErix induced an IgG response against the C-terminal portion of OspA, which corresponds 
to the protective conformational epitope LA-2 (Sears et al., 1991).  LYMErix was protective in 
~80% of those vaccinated, although maintenance of high antibody titers was required for the 
vaccine to be effective (Steere et al., 1998; Sigal et al., 1998).  To achieve adequate titers, over 
the course of one tick transmission season, three boosters were administered (Sigal et al., 1998).  
This ensured sufficient antibody was taken into the tick midgut with the blood meal.  Since 
OspA antibodies are borreliacidal (de Silva et al., 1996) the vaccine neutralized B. burgdorferi 
and prevented transmission.     
 Of the 1.4 million doses of the vaccine sold, there were 905 reported adverse side effects 
with 102 being arthritis.  However, the rate of arthritis was below the background occurrence 
within the general population (Lathrop et al., 2002).  Despite this fact, numerous lawsuits were 
filed including a class action lawsuit in 1999 (Abbott, 2006).  Subsequent studies found no 
conclusive link between development of arthritis and those vaccinated with LYMErix.  There 
was also a concern that sequence homology between an OspA T-cell epitope (OspA163-175) and 
the human leukocyte function antigen 1 (LFA-1α326-345) in persons with HLA haplotype [DRB 
0401] led to induction of autoimmune arthritis (Gross and Huber, 2000; Trollmo et al., 2001).  
However, further studies conclusively proved this was not the case (Chen et al., 1999; Gross and 
Huber, 2000; Drouin et al., 2008).  Despite convincing scientific data to the contrary, the public 
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was convinced LYMErix was unsafe.  The bad press of the lawsuits caused vaccine sales to 
plummet and GSK had no choice but to discontinue the vaccine in 2002.   
 Other surface lipoproteins are candidates for the next generation LD vaccine.  Possible 
candidates along with their functions, expression, and immunogenicity are detailed in Table 1.1.  
OspC is an especially promising candidate as it is expressed at high amounts early in the 
infections cycle, its genetic locus is stable, it is abundant on the surface and it elicits a robust 
adaptive and innate immune response.  One drawback to OspC vaccination is the great deal of 
heterogeneity between strains at the ospC locus.  However, a multivalent OspC vaccine 
composed of the major serotypes is possible (Wang et al., 1999).   
 
Table 1.1. Protection of Experimental Animals from B. burgdorferi challenge.   
Immunizing Protein Protection Function     Expression  
OspA   +++++  Tick adhesin/Protects against acquired immunity Tick 
OspB   ++++  Tick adhesin     Tick 
OspC   +++  Disseminating factor/Establish infection  Tick/Host 
OspE   -  Complement binding    Host 
OspF   +  Complement binding    Host 
FlaB (negative control) -  Flagella      Constitutive 
P66   +  Outer membrane porin    Constitutive 
DbpA   ++  Binds decorin     Host 
 
Data in table is from (A. Plotkin et al., 2008).   
 
Another intriguing possibility for LD vaccination is the use of tick proteins. Arthropod 
vectors typically transmit a milieu of secreted proteins when a blood meal is taken, which elicits 
an immune response (Wikel, 1997; Wikel and Bergman, 1997).  A study by Dai et al. showed 
immunization of mice with a tick salivary gland protein, Salp15 (Ramamoorthi et al., 2005; 
Schuijt et al., 2008), significantly protected mice upon B. burgdorferi challenge.  The use of a 
vector protein as a vaccine was also successful in immunizing hamsters against the protozoan 
parasite Leishmania (Gomes et al., 2008).  Moving forward, this approach validates vector 
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proteins as the basis for future LD vaccines.  It will be interesting to determine if a vaccine 
consisting of I. scapularis and B. burgdorferi antigens will yield a more effective LD vaccine.   
 
Tick Borne Relapsing Fever 
TBRF is a worldwide disease with most cases occurring in Africa (Goubau, 1984).  Although 
sporadic outbreaks of TBRF occur in the western United States there are only ~25 annual cases 
((CDC), 2003; (CDC), 2007).  Ornithodoros soft ticks, responsible for transmission, take short 
blood meals lasting 15-90 minutes (E. Sonenshine, 1997), which is significantly shorter than 
Ixodes blood meals.  The Borrelia species that are transmitted by Ornithodoros ticks take their 
species name by the Ornithodoros species responsible for transmission.  For example, the two 
Borrelia species that are most common in the United States, B. hermsii and B. turicatae, are 
transmitted by O. hermsi and O. turicata, respectively (Larsson et al., 2009; Dworkin et al., 
2008). 
 TBRF is characterized by recurring episodes of fever, fatigue, headache, malaise, and 
muscle aches.  The incubation period is about 7 days, and is followed by a fever that may or may 
not accompany the aforementioned symptoms.  The fever lasts about 3 days and resolves on its 
own.  About 7 days later, the first relapse occurs with symptoms identical to the initial fever.  
This cycle can continue in untreated persons up to 10 times (Southern and Sanford, 1969). The 
person may experience malaise or feel normal between febrile episodes.  The causes of febrile 
symptoms are high levels of spirochetes in the bloodstream (107-108 cells/ml blood), which is 
significantly higher than LD Borrelia (Stoenner et al., 1982).  A course of antibiotics can treat 
the infection with chloramphenicol, doxycycline, and erythromycin being the drugs of choice (L. 
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Kasper and Randolph Harrison, 2005).  The mortality rate if left untreated is 4-10% (Dai et al., 
2006). 
 
Antigenic variation and tissue tropism in tick borne relapsing fever Borrelia 
The continued recurrence/cessation of febrile symptoms is a direct result of antigenic variation.  
Seroconversion effectively neutralizes 90% of the bacterial population while the remaining 10% 
undergo an antigenic switch via the variable membrane-like large (~36kDa) and variable 
membrane-like small (~20kDa) proteins or Vlp and Vsp, respectively (Stoenner et al., 1982; 
Barbour, 1990; Schwan and Hinnebusch, 1998).  The mechanism of antigenic variation is 
different than the switching of silent gene cassettes that occurs at the vlsE locus in B. burgdorferi 
(described above).  In B. hermsii, antigenic variation is governed by gene conversion involving 
recombination at upstream and downstream homology sequences (UHS and DHS) that replaces 
the vsp or vlp genes at the expression site.  The UHS and DHS are located on a storage plasmid 
and recombination occurs downstream of the promoter on the expression plasmid.  This results 
in a new Vsp or Vlp protein that is not recognized by the antibodies synthesized in response to 
the first antigen (Rich et al., 2001; Barbour et al., 2000).  The spirochetes are one step ahead of 
the adaptive immune system as they multiply in the bloodstream and cause a relapse in febrile 
symptoms.  The cycle continues until seroconversion eliminates all the spirochetes, or until the 
infected person is treated with antibiotics (Dai et al., 2006; Barbour et al., 2000; Burman et al., 
1990; Kitten and Barbour, 1992).   
Two distinct serotypes of B. turicatae Vsp (Vsp1 and Vsp2) exhibit differential tissue 
tropism.  Borreliae that express Vsp1 preferentially invade the central nervous system of the 
host, while expression of Vsp2 results in spirochetemia and systemic illness (Cadavid et al., 
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1997; Cadavid et al., 1994; Pennington and Cadavid, 1999; Cadavid et al., 1993; Pennington et 
al., 1997). The Vsps also bind glycosaminoglycans (GAGs), which enhances invasiveness 
(Magoun et al., 2000; Zückert et al., 2001).  Vsp1, and to a lesser extend Vsp2, can disseminate 
from the periphery and inflame the brain (Londoño and Cadavid, 2010).  Furthermore, 
interaction with the brain endothelium occurs via the lipid moiety and the variable dome region 
of Vsp1 (Gandhi et al., 2010) 
 
Bacteriology 
Borrelia spp belong to an atypical phylum of bacteria called the spirochetes, named for their 
wavelike morphology (Fig 1.1A).  Members include Treponema pallidum (Syphilis) and 
Leptospira interrogans (Leptospirosis) (Hyde and Johnson, 1984; Haake and Matsunaga, 2010).  
Borrelia cells are 3-25 µm in length, 0.2-0.5 µm wide, and are diderm i.e., they contain two 
membranes that sandwich a periplasmic space.  Double membrane envelope architecture is 
common among Gram-negative bacteria.  However, Borrelia possesses distinct characteristics 
that make it difficult to classify.  Unlike most bacteria the morphology of Borrelia cells is 
dependent on the periplasmic flagella and not peptidoglycan, although peptidoglycan does play a 
role in determining the overall rod shape of the cell cylinder (Motaleb et al., 2000).   
The fragmented genome of B. burgdorferi also contains unusual characteristics such as 
high A/T content (~70%), a 0.9 MB linear chromosome and ~600 kb in linear and circular 
plasmids (Casjens and Huang, 1993; Baril et al., 1989; Ferdows and Barbour, 1989; Stewart et 
al., 2005).  Interestingly, most of these plasmids are unnecessary for in vitro growth (and are 
readily cured when grown in vitro) yet contain gene products that are indispensable during the 
course of mammalian infection (Schwan et al., 1988; Skare et al., 1999; Skare et al., 1995).  
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Unlike Treponema pallidum, Borrelia can be cultivated in vitro using a complex, undefined 
medium developed by Alan Barbour, Herbert Stoenner, and Richard Kelly (BSK) (Zückert, 
2007; Barbour, 1984; Kelly, 1971; Stoenner, 1974).   The doubling time of Borrelia cells is 
relatively long  (5-18 hours) when compared to E. coli and other bacteria, which can be as short 
as 20-30 minutes (Zückert, 2007; Stevenson et al., 1995). 
Although Borrelia stains weakly negative when subjected to gram staining (Aberer and 
Duray, 1991), the spirochete is not considered gram negative due to the absence of 
lipopolysaccharide (LPS) in the cell envelope (Takayama et al., 1987).  Glycolipids, termed 
BbGL-1 and BbGL-II, comprise 36% of the total lipid mass in Borrelia and may function as a 
substitute for LPS.  Since Borrelia glycolipids share certain characteristics with LPS, i.e., are 
surface exposed, conform to a three-domain structure, and are abundant they could play a role in 
stabilizing the envelope.  Thus, these glycolipids could function analogous to the role of LPS in 
Gram-negative bacteria (Schröder et al., 2003; Ben-Menachem et al., 2003; Östberg et al., 2007).  
Phospholipid composition and high lipoprotein content are other distinctive features of the 
Borrelia cell envelope.  The phospholipid composition in the E. coli envelope is 
phosphatidylglycerol (PG) (65-70%), cardolipin (CL) and phosphatidylethanolamine (PE) (30-
35%).  On the other hand, B. burgdorferi lipid bilayers contain only phosphatidylcholine (PC) 
(~80%) and PG (~20%) (Belisle et al., 1994; Wang et al., 2004).  The E. coli proteome contains 
~90 lipoproteins that are largely localized to the periplasmic face of outer membrane and 
function to maintain envelope integrity (Gennity and Inouye, 1991), although a subset of Braun’s 
lipoprotein seems to have a surface exposed domain (Cowles et al., 2011).  The B. burgdorferi 
proteome contains ~127 lipoproteins (~7.8% of all ORFs) (Setubal et al., 2006; Eggers et al., 
2000; Fraser et al., 1997) that are largely localized to the outer surface and function as virulence 
 13 
factors (Skare et al., 1995).  Surface localization of lipoproteins is absolutely essential in 
establishing and maintaining infection.  Thus, a complex regulatory network that ensures proper 
expression of lipoproteins adapted for specific stages of the infectious process is necessary.  
  
Differential regulation of B. burgdorferi lipoproteins during the infectious cycle 
Over the past decade vigorous research has been conducted to elucidate the molecular 
mechanisms that govern differential gene regulation as B. burgdorferi progresses through the 
arthropod-mammalian infectious cycle.  Schwan and Piesman made the initial observation that 
there was reciprocal regulation of two surface lipoproteins, OspA and OspC, at 23°C and 35°C 
(Schwan and Piesman, 2000), respectively.  More recently, Srivastava and Silva have more 
precisely defined reciprocal expression of OspA and OspC at the single cell level (Srivastava and 
Silva, 2008).  The 23°C to 35°C temperature shift mimics the change in environment from the 
arthropod vector to the mammalian host.  Whole genome array analysis determined 200 ORFS 
were differentially regulated at 23°C and 35°C.  One hundred-thirty ORFs were upregulated at 
35°C, while 82 were upregulated at 23°C (Ojaimi et al., 2003).  A complex global regulatory 
pathway, the Rrp2-RpoN-RpoS pathway, is responsible for differential regulation of lipoprotein 
coding genes during the infectious process.  ospA, ospB, ospC, dbpA, bbk32 and vleE are a few 
examples of lipoprotein encoding genes regulated by this pathway (Ouyang et al., 2008; Hubner 
et al., 2001; Caimano et al., 2004; Caimano et al., 2005; Fisher et al., 2005).  Most experimental 
data is based on the relationship between OspA/B and OspC and will be the focus of discussion. 
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OspA and OspB 
ospA and ospB are two lipoprotein-encoding genes that make up the ospAB operon located on the 
54-kb linear plasmid (lp54) (Howe et al., 1986).  Although both lipoproteins are synthesized in 
abundance during in vitro culture, expression during the course of mammalian infection is low.  
However, in the midguts of unfed ticks OspA and OspB are expressed at significantly higher 
levels (Stevenson et al., 1995; Liang et al., 2004).  OspA facilitates adhesion to the tick midgut 
via the tick receptor for outer surface protein A, or TROSPA (Pal et al., 2000; Pal et al., 2001; 
Pal et al., 2004a).  However, a study by Battisti et al., showed OspA deficient B. burgdorferi 
cells still bound tick midgut extracts, persisted within the midgut, and were able to infect mice.  
The authors propose OspA functions to protect B. burgdorferi from acquired host immunity upon 
the influx of immune blood from the host and is dispensable for midgut adhesion (Battisti et al., 
2008).  OspB serves a similar function as OspA as it binds to tick midgut extracts and ospB 
knockout strains are unable to colonize ticks (Neelakanta et al., 2007; Fikrig et al., 2004).  Both 
lipoproteins are monomeric and consist of an open β-sheet with the C-terminus confined to a 
short α-helix (Fig. 1.2D) (Li et al., 1997; Becker et al., 2005).  OspA and OspB are rapidly 
downregulated once the tick takes a blood meal and environmental conditions change 
(temperature, pH, oxygen, and CO2).  This mechanism facilitates detachment from the midgut, 
migration to the salivary glands and OspC synthesis (Liang et al., 2004; Brooks et al., 2003; 
Schwan et al., 1995; Schwan and Piesman, 2000). 
 
OspC 
OspC is a α-helical dimer (Eicken et al., 2001; Kumaran et al., 2001; Zückert et al., 2001) (Fig. 
1.2A) encoded on the 26-kb circular plasmid (cp26).  Cp26 cannot be cured under normal 
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circumstances (Jewett et al., 2007).   OspC shares significant sequence and structural homology 
to the B. turicatae neurotropic lipoprotein Vsp1 (Fig. 1.2B) and B. burgdorferi VlsE, (Fig 1.2C) 
(Lawson et al., 2006; Zückert et al., 2001; Eicken et al., 2002).  Other than the aforementioned 
lipoproteins, OspC only shares structural homology with the periplasmic domain of the 
Salmonella typhimurium aspartate receptor (15% amino acid identity) (Eicken et al., 2001; 
Kumaran et al., 2001; Yeh et al., 1996). 
OspC is synthesized upon tick feeding and during the initial stages of infection.  Further 
investigation revealed OspC is required for the establishment of mammalian infection (Grimm et 
al., 2004; Stewart et al., 2006; Tilly et al., 2006; Tilly et al., 2007), which appears to be further 
enhanced by binding to Salp15, an immune-modulating tick salivary gland protein (Anguita et 
al., 2002; Garg et al., 2006; Ramamoorthi et al., 2005).  Salp15 is thought to coat the surface of 
B. burgdorferi and provide protection against antibody-mediated lysis (Schuijt et al., 2008).  
OspC has also been show to bind plasminogen, which presumably enhances invasiveness (Lagal 
et al., 2006).  Despite providing these seemingly essential functions, Xu et al. showed that 
unrelated lipoproteins (DbpA, OspA, OspE), as well as VlsE were able to restore infectivity to 
strains that lack OspC.  This calls into question the importance of OspC and emphasizes the 
composition of the borrelial surface and the general function of lipoproteins in stabilization of 
the outer membrane during infection (Xu et al., 2008).  Indeed, the precise function of OspC is 
still the subject of considerable debate.  The mechanism of differential regulation of OspA/B and 
OspC is a central paradigm of B. burgdorferi research and will be discussed in detail below.   
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Gene regulation via the Rrp2-RpoN-RpoS pathway 
Changes in temperature, pH, cell density, CO2 and oxygen are thought to be some of the external 
cues B. burgdorferi utilizes to down regulate genes associated with arthropod persistence, and 
upregulate genes involved in mammalian infection (Schwan et al., 1995; Indest et al., 1997; 
Carroll et al., 1999; Yang et al., 2000; Stevenson et al., 1995; Hyde et al., 2007).  These cues 
lead to the induction of the Rrp2-RpoN-RpoS pathway that eventually leads to upregulation of 
ospC and other genes required for host adaptation.  Phosphorylation and subsequent activation of 
Rrp2, which is the transcriptional activator of RpoN (σ54), occurs by the small molecular weight 
high-energy phosphoryl-donor acetyl phosphate (acetyl~P) (Xu et al., 2010a).  RpoN then binds 
the σ54 dependent promoter of RpoS (σS) (Elias et al., 2000; Yang et al., 2000; Fisher et al., 
2005; Hübner et al., 2001; Smith et al., 2007) and RpoS binds σS dependent promoters.  As an 
additional level of post-transcriptional control, a small regulatory RNA (DsrABb) binds the 
upstream region of the rpoS mRNA at 37°C, but not 23°C, permitting the ribosome to access the 
ribosome-binding site and translation to proceed (Lybecker and Samuels, 2007).  The proposed 
role of DsrABb is that of a molecular thermometer, as it only regulates rpoS mRNA levels in 
response to temperature and not in response to pH and cell density (Lybecker and Samuels, 
2007) (Fig. 1.3).   
 The ultimate result of this complex signaling cascade is upregulation of OspC and other 
gene products involved in mammalian infection, while the tick associated genes (Caimano et al., 
2005) are downregulated.  An elegant study used flow cytometry to characterize OspA and OspC 
expression at the single cell level (Srivastava and Silva, 2008). Srivastava and Silva showed 
OspA and OspC expression is binary, i.e., the same cells that downregulate OspA are the same 
ones that upregulate OspC.  An independent study by He et al. showed cells expressing OspC at 
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high levels do not express OspA, and abrogation of the ospAB operon leads to constitutive 
activation of the RrpS-RpoN-RpoS pathway (He et al., 2008).  The authors proposed activation 
of the RpoN-RpoS pathway in conjunction with downregulation of OspA forms a positive 
feedback loop that further upregulates the Rrp2-RpoN-RpoS pathway.  This mechanism insures 
the adequate production of OspC and other lipoproteins involved in mammalian infection (He et 
al., 2008) (Fig 1.3).  Indeed, detailed information is available on the subject of differential 
regulation of OspA and OspC, but how do these lipoproteins reach the bacterial surface?  Before 
we can attempt to answer this question it is important to understand how lipoproteins synthesized 
are trafficked in other bacteria. 
 
Lipoprotein structure and biosynthesis  
Lipoproteins are synthesized in the cytoplasm with an N-terminal signal peptide (~20 residues in 
length) that directs the unfolded polypeptide to the periplasm via the SecYEG translocon located 
in the cytoplasmic membrane (Manting and Driessen, 2000).  Once Sec-dependent translocation 
of the pre-lipoprotein is complete, two acyl chains are added to a conserved N-terminal cysteine 
residue by lipoprotein diacylglycerol transferase (Lgt).   The N-terminal signal peptide is then 
proteolytically removed by the lipoprotein signal peptidase (Lsp), more commonly known as 
signal peptidase II.  Lipidation and signal peptide cleavage are determined by the presence of the 
lipobox motif at the C-terminal end of the signal peptide (Figure 1.4) (Choi et al., 1987; 
Sankaran and Wu, 1994; Qi et al., 1995). The spirochetal lipobox is 4 amino acids long and 
defined as follows:  Leu(Ala,Ser,Val,Phe,Ile)-4-Leu(Val,Phe,Ile)−3-Ile(Val,Gly)-2- 
Ala(Ser,Gly,Asn,Cys)-1-↓Cys+1 (Haake, 2000; Setubal et al., 2006). Compared to the E. coli 
lipobox: Leu(Ala,Val)−4-Leu−3-Ala(Ser)−2-Gly(Ala)−1-↓Cys+1 (↓ denotes the Lsp cleavage site 
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and Cys+1 is lipidated Cys) (Wu and Tokunaga, 1986), the spirochetal lipobox exhibits a higher 
degree of plasticity, presumably to tolerate the difference in active site specificities in the 
lipidiation and signal peptidase machinery (Paetzel et al., 2002).  The final acyl chain is then 
added by the lipoprotein N-acyl transferase (Lnt) yielding the mature lipoprotein (Figure 1.4).  
All these steps occur while the lipoprotein is associated with the inner membrane and the 
corresponding enzymes are conserved across most bacterial species (Qi et al., 1995; Jackowski 
and Rock, 1986; Tokunaga et al., 1982).  Lipoproteins are either retained in the inner membrane 
or sorted via the Lol (localization of lipoproteins) machinery across the periplasm to the outer 
membrane.  There, the lipoproteins are either anchored to the periplasmic face of the outer 
membrane or translocated across the outer membrane to the surface of the cell (Zückert et al., 
2004; Schulze and Zückert, 2006). 
 
Lipoprotein sorting in E. coli 
Once lipidation and signal peptide cleavage is complete, the mature lipoprotein is shunted to the 
LolCDE machinery (stoichiometry C1D2E1) located in the cytoplasmic membrane.  LolCDE is an 
essential ABC transporter dedicated to the transport of lipoproteins, thus playing a vital role in 
outer membrane biogenesis (Yakushi et al., 2000; Ruiz et al., 2006; Silhavy et al., 2010).  
LolCDE releases lipoproteins, by hydrolysis of ATP, to LolA which functions as a periplasmic 
lipoprotein transit chaperone (Matsuyama et al., 1997).  LolA binds to the lipoprotein via the 
lipid moiety, creates a water-soluble complex and delivers the lipoprotein to the outer membrane 
lipoprotein receptor LolB (Yokota et al., 1999; Yakushi et al., 1998).  Finally, the lipoprotein is 
anchored to the periplasmic face of the outer membrane (Okuda and Tokuda, 2009; Tsukahara et 
al., 2009) (Fig. 1.5).  Most lipoproteins in E. coli and other enterobacteriaceae are localized to 
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the outer membrane and are essential to maintain integrity of the cell envelope e.g., Lpp and Pal 
(Ruiz et al., 2006; Cascales et al., 2002).  However, there are some lipoproteins anchored to the 
inner membrane that avoid interaction with LolCDE (Fig. 1.5).  These lipoproteins share a 
common aspartic acid in the +2 position immediately downstream of the lipidated cysteine.  This 
is illustrated as follows: 
         Lipobox     ↓   
-4     -3    -2    -1    +1    +2   +3   +4           Envelope Localization 
Lpp   L      L     A    G     C      S      S     N     Outer membrane 
Lipoprotein-28 L      L     A    G     C      D     Q     S    Inner membrane 
↓denotes the signal peptidase II (Lsp) cleavage site. 
 
 
The +2 Asp functions as a LolCDE avoidance signal, and is commonly known as the +2 rule.  If 
any other amino acid is present in the  +2 position, the lipoprotein is permissive for interaction 
with LolCDE and sorted to the outer membrane (Yamaguchi et al., 1988).  Interestingly, a study 
by Seydel et al. found the amino acids phenylalanine, tryptophan, tyrosine, glycine, and proline 
could also act as Lol avoidance signals (Seydel et al., 1999).  Upon further investigation, it was 
determined that the aforementioned amino acids are never present in the +2 position of native 
lipoproteins and do not represent true inner membrane retention signals. 
 The mechanism of Lol avoidance is dependent on the distance between the negative 
charge of the Cα of the +2 residue (2.72-3.5 Å) and phosphatidylethanolamine (PE).  When Asp 
is in the +2 position, the negative charge of the side chain forms a tight complex with PE that 
contains five acyl chains and is unable to interact with LolCDE.  Glu cannot satisfy this 
requirement because the negative charge is too far (4.24-4.93 Å) from the Cα of the +2 residue, 
but oxidation of Cys to cysteic acid can act as an avoidance signal because the negative charge is 
within range (2.87-3.95 Å) (Hara et al., 2003; Robichon et al., 2005).  Inner membrane retention 
is enhanced when Asp, Glu, and Gln are in the +3 position (Terada et al., 2001).  The positive 
 20 
charge of PE was also found to be crucial, as amine specific modification of PE or replacement 
with cardiolipin abolished LolCDE avoidance despite the presence of Asp in the +2 position 
(Hara et al., 2003).  Since Borrelia lack PE (Belisle et al., 1994) this is a possible explanation on 
why the +2 rule does not apply.  The reason Phe, Trp, Pro, Gly, and Tyr act as inner membrane 
retention signals is not explained by the +2 rule and is likely due to a different mechanism that 
has yet to be elucidated.  The +2 rule also extends to other members of Enterobacteriaceae 
(Shigella flexneri, Salmonella enterica, Yersinia pseduotouberulosis, and Erwinia carotovora) 
(Lewenza et al., 2006).  Variations of the +2 rule also exist, as Pseudomonas aeruginosa 
lipoprotein sorting signals are located at positions +3 and +4 (Naritia and Tokuda, 2007).  
Overall, surface exposure of lipoproteins is rare in bacteria, although surface presentation occurs 
via the autotransporter (Type V), Type II (T2SS) secretion systems.  In addition to secretion 
system mediated surface localization, a subset of an abundant E. coli ‘outer membrane’ 
lipoprotein seems to be surface exposed (Cowles et al., 2011).   
 
Surface localization of lipoproteins in other bacteria 
Autotransporters represent a large superfamily of bacterial transporters that are quite diverse in 
function and size (<20 to >400 kDa), but their basic structure is composed of an N-terminal 
signal peptide, an N-terminal extracellular passenger domain and a C-terminal β-barrel (β 
domain) (Pohlner et al., 1987; Pallen et al., 2003).  It was once widely accepted that the β 
domain assembles a pore in the outer membrane that mediates translocation of the passenger 
domain to the surface after SecYEG dependent secretion to the periplasm.  ‘Autotransporters’ 
was termed such because of the perceived self-contained nature of the protein translocation 
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system (Pohlner et al., 1987).  This notion has since been called into question, and the exact 
mechanism of how autotransporters cross the outer membrane remains a subject of debate.   
A recent report by Ieva and Bernstein, shows direct interaction between the E. coli EspP 
autotransporter passenger and β domains with BamA (β-barrel assembly machinery, also known 
as Omp85/YaeT) (Gentle et al., 2005; Ieva and Bernstein, 2009).  BamA functions to insert 
integral outer membrane proteins (OMPs) into the outer membrane (Gentle et al., 2005).  This 
data strongly supports the model of insertion of the β domain in the outer membrane by BamA 
and subsequent translocation of the passenger domain.  Some autotransporters are lipoproteins, 
including Bordetella pertussis subtilisin SphB1 and Neisseria meningitidis serine protease NalP 
(Coutte et al., 2003; van Ulsen et al., 2003).  These lipoproteins represent some of the rare 
exceptions of surface exposed lipoproteins that occur in bacteria other than Borrelia.  However, 
their functions as proteases are distinct in comparison to the functions of Borrelia lipoproteins.   
 Other examples of surface exposed lipoproteins are Pullulanase (PulA) in Klebsiella 
oxytoca, and MtrC, and OmcA in Shewanella oneidensis.  These lipoproteins reach the surface 
via the Type II Secretion System (T2SS) after SecYEG dependent secretion to the periplasm 
(d'Enfert et al., 1987; Shi et al., 2008).  In the absence of the T2SS, localization of PulA is 
dependent on the +2 rule.  Only when the T2SS is present is PulA localized to the bacterial 
surface (Pugsley, 1993).  Another example of a surface exposed lipoprotein is free-form Braun’s 
lipoprotein (Lpp) (Cowles et al., 2011).  Lpp is an extremely abundant outer membrane 
lipoprotein that exists in two forms:  the bound form that is bound to peptidoglycan (Fig 1.5) and 
the free form that is not (Braun and Rehn, 1969; Braun and Bosch, 1972; Braun and Wolff, 
1970).  Cowles et al. recently showed that the free form of Lpp is surface exposed (Cowles et al., 
2011).  The free form Lpp trimer is likely anchored to the periplasmic face of the outer 
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membrane and spans the outer lipid bilayer in such a way that the C-terminus is surface exposed 
(Bernstein, 2011). 
 
Lipoprotein sorting in B. burgdorferi  
The B. burgdorferi cell envelope contains many distinct features (see bacteriology section).  
However, the pathways involved in insertion of β-barrel proteins in the outer membrane as well 
as the essential periplasmic chaperones seem to be conserved (Bergström et al., 2010), e.g., 
DegP, SurA, and Skp.  Additionally, CtpA is another periplasmic protease that is not commonly 
found in the proteomes of eubacteria.  With the exception of CtpA, these proteins have not been 
characterized in B. burgdorferi.  CtpA is an unusual serine-like C-terminal protease with 
homologues in T. pallidum and other bacteria.  Östberg et al. made the observation that 
inactivation of ctpA in B. burgdorferi resulted in an altered protein expression profile, but did not 
significantly affect in vitro growth (Östberg et al., 2004).   Two of the proteins identified in this 
study were the lipoprotein BB0323 and P13, an outer membrane porin.  Both of these proteins 
had a C-terminal processing defect, but it did not seem to influence localization within the 
envelope (Östberg et al., 2004).   Previous studies showed inactivation of bb0323 caused 
significant membrane blebbing that led to considerable defects in envelope stability (Zhang et 
al., 2009; Stewart et al., 2004).  It is possible that CtpA modifies other lipoproteins in the process 
of outer membrane biogenesis and maintenance of envelope homeostasis.   
Our knowledge of Borrelia lipoprotein sorting is still in its infancy.  B. burgdorferi 
contains homologues of all the proteins of the Lol machinery with the exception of the outer 
membrane lipoprotein receptor, LolB.  Although existence of a LolB-like protein with little 
sequence homology is certainly possible no protein has been assigned this function, to date.  
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From preliminary studies, LolA has been shown to interact with outer membrane and surface 
lipoproteins, but not inner membrane lipoproteins, which is consistent with the E. coli Lol 
system (Bridges and Zückert, unpublished data).  B. burgdorferi Lol homologues share 
significant sequence homology with the E. coli Lol proteins, so it is reasonable to postulate that 
they function in a similar way. 
 What are the requirements for proper localization of Borrelia lipoproteins?  Schulze and 
Zückert first began to address this question when they made N-terminal fusions of OspA to a 
monomeric red fluorescent reporter protein (mRFP1) and found that mRFP1 localized to the B. 
burgdorferi cell surface.  A minimum of five amino acids of the mature lipoprotein was 
sufficient for proper surface localization, as fusions of less than five amino acids were localized 
to the periplasm.  Negative charges could also act to retain these OspA lipo-mRFP1 fusions in 
the inner membrane when they were present in a certain context. Alanine mutagenesis of 
OspA28:mRFP1 had no effect on surface localization of mRFP1.  Surprisingly, a fusion of an 
inner membrane lipoprotein, OppAIV, to mRFP1 was also localized to the cell surface.  Taken 
together, these results led to the model of B. burgdorferi lipoproteins localized to the surface by 
default (Schulze and Zückert, 2006).  This study also was important in showing lipoproteins of 
B. burgdorferi do not adhere to the established +2 rule in E. coli, or the +2/+3/+4 rule that other 
bacteria follow (Narita and Tokuda, 2007).   
 In a follow up study again using OspA as a model lipoprotein, Schulze et al. found four 
N-terminal amino acids of mRFP1 (ASSE) artificially increased the length of the N-terminal 
mature region of the lipo-RFP fusion.  Removal of these four residues resulted in a new reporter 
(mRFPΔ4) (Schulze et al., 2010), and localization of OspA:mRFPΔ4 fusions and mutants were 
consistent with localization of OspA mutants not fused with mRFPΔ4.  More importantly, this 
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study also identified a tetrapeptide in OspA (V21S22S23L24) that was essential in localization of 
OspA to the surface.   Single amino acid deletions of any of these four residues led to 
mislocalzation of OspA to the periplasmic face of the outer membrane.  Further analysis using C-
terminal epitope tagged variants of OspA in conjunction with C-terminal destabilizing mutations 
revealed that secretion of OspA across the outer membrane requires an unfolded confirmation 
that initiates at the C-terminus (Schulze et al., 2010).  Finally, the mechanism of lipoprotein 
transport and outer membrane biogenesis is likely conserved across all species of Borrelia as B. 
burgdorferi correctly localizes the B. turicatae lipoproteins Vsp1 and Vsp2 to the spirochetal 
surface (Zückert et al., 2004).  
  
The lipoprotein tether 
All Borrelia lipoproteins seem to contain a disordered stretch of amino acids located at the 
extreme N-terminus of the mature lipoprotein.  Crystallization data indicates that these N-
terminal residues are either void of election density or lack any secondary structure.  We 
envision a model in which the lipoprotein is anchored to the membrane via the lipid moiety and 
the N-terminal disordered amino acids acts as a flexible linker (Fig 1.4).  This linker functions to 
‘tether’ the structurally confined portion of the lipoprotein to the lipid bilayer. Thus, we have 
termed this portion of the lipoprotein the ‘tether’.  We hypothesize that the tether residues must 
adopt a certain degree of flexibility necessary for interaction with a periplasmic chaperone.  In 
support of this hypothesis, replacement of the OspA VSSL tetrapeptide with alanines was 
permissive for surface translocation, while replacement with glycines was not.     
 The primary sequence of the tether is highly variable (Schulze et al., 2010) with the 
exception of the absolutely conserved +1 Cys.  Primary sequence alignment of all known and 
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predicted B. burgdorferi lipoproteins from the +1 Cys onward failed to identify a canonical motif 
or sorting ‘signal’ (Schulze et al., 2010).  Therefore, it is difficult to determine if sorting rules are 
based on amino acid identity alone.  A random mutagenesis approach would be a viable strategy 
in ascertaining the answer to this question.  Our current hypothesis states that regions of the 
tether must interact with a periplasmic chaperone and subsequently an outer membrane 
lipoprotein translocon or ‘flippase’.  This ‘flippase’ would function to translocate surface 
lipoproteins across the outer membrane and to the bacterial surface.  To date, all attempts to 
identify this protein using classic protein-protein interaction techniques, such as co-
immunoprecipitation, epitope tag pulldowns, yeast two-hybrid screens, and biotinylation assays 
have yielded inconsistent results.  Future approaches will make use of conditional knockout 
mutants of chromosomally encoded integral outer membrane proteins that have not been 
characterized (Table 7.1) (Whetstine et al., 2009).  One such conditional knockout has already 
been characterized using the B. burgdorferi BamA homologue (BB0795) (Lenhart and Akins, 
2010).  Depletion of BB0795 resulted in a reduction of lipoproteins in the outer membrane, 
although this effect might be secondary (Lenhart and Akins, 2010) as BB0795 may be 
responsible for insertion of the aforementioned outer membrane lipoprotein flippase. 
 
The role of oligomerization in the translocation process 
Eubacteria have evolved a diverse number of mechanisms to transport proteins across cell 
membranes.  Although explanation of each secretion mechanism is beyond the scope of this 
dissertation, a brief comparison of two systems:  the Sec and the Tat translocons are important. 
The Sec translocase exports unfolded proteins across the cytoplasmic membrane via hydrolysis 
of ATP and cannot tolerate folded substrates.  The Tat translocase also exports proteins across 
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the cytoplasmic membrane, but can only tolerate folded substrates and utilizes the proton motive 
force as an energy source (Manting and Driessen, 2000; DeLisa et al., 2003).  The oligomeric 
state of lipoproteins during translocation is one of the questions addressed in this dissertation.  
Are lipoproteins translocated across the outer membrane in their final, oligomeric conformation 
or is a monomer necessary for export?  In the case of the Sec translocon, oligomerization occurs 
in the periplasm and premature oligomerization leads to a block in secretion (Natale et al., 2008).  
On the other hand, failure of Tat substrates to oligomerize prior to translcoation results in a 
translocation block (Jack et al., 2004).  What are the oligomeric requirements for lipoprotein 
sorting through the outer membrane?  Answering this question would provide important 
information regarding the nature of the outer membrane ‘flippase.’ 
The experimental work presented in this dissertation has focused on elucidating the 
requirements that govern localization of lipoproteins.  We have used many approaches in an 
attempt to answer this question and further define the rules of lipoprotein sorting in B. 
burgdorferi.  Our first approach used random mutagenesis in combination with FACS to identify 
novel periplasmic localization signals (Chapter III).  We then shifted the focus of our studies to 
the dimeric OspC-Vsp lipoprotein family to further define the role of oligomerization during the 
translocation process (Chapter IV) and to directly compare factors that influence surface 
localization to OspA.  During the course of these two main projects we further defined the role of 
a periplasmic C-terminal protease, CtpA, which proteolytically cleaves certain lipoproteins 
(Chapter V).  This finding gave us some insight to the role of CtpA in envelope biogenesis.  
Finally, we expressed a lipoprotein native to E. coli in B. burgdorferi and localized it within the 
envelope (Chapter VI).   
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Figure 1.1.  Etiology of Lyme disease.   
(A) A single B. burgdorferi cell stained with DAPI under 40X magnification.  Image was taken 
and processed by Ozan Kumru.  (B) Whole mount of an Ixodes scapularis nymph.  Image kindly 
provided, with permission, by Dr. Steve Upton, Kansas State University Parasitology (Upton, 
1999).  (C) Erythema migrans rash that commonly develops at the site of the tick bite and is a 
telltale sign of Lyme disease.  Image kindly provided by James Gathany of the CDC with 
permission.   
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Figure 1.2.  Crystal structures of Borrelia lipoproteins.   
Crystal structures of the Borrelia lipoproteins (A) OspC, (B) Vsp1, (C) VlsE and (D) OspA.  N 
and C termini are indicated.  PDB accession numbers are 1GGQ, 1YJG, 1L8W, and 3EEX 
respectively.   
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Figure 1.3.  The Rrp2-RpoN-RpoS pathway. 
Environmental changes activate a signaling cascade that culminates in the activation of rpoS (σS) 
that binds the promoters of genes whose products are involved in mammalian infection.  Many of 
the gene products are lipoproteins, including OspC (Burtnick et al., 2007; He et al., 2008; 
Lybecker and Samuels, 2007; Xu et al., 2010a; Caimano et al., 2007).  Figure is not drawn to 
scale.  See text for details.   
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Figure 1.4.  Borrelia lipoprotein structure and biogenesis. 
Borrelia lipoproteins are synthesized in the cytoplasm and directed to the inner membrane 
SecYEG translocon by the N-terminal signal peptide.  The lipobox motif ensures the protein is 
diacylated at the +1 Cys by Lgt, followed by proteolytic cleavage of the signal peptide by Lsp. 
Finally, Lnt adds the third acyl chain via an amine linkage at the +1 Cys.  The lipoprotein is now 
fully mature and is then sorted through the Lol machinery depending on the composition of the 
lipoprotein tether (see text for details).  Figure is not drawn to scale.  Figure was inspired by 
(Kovacs-Simon et al., 2010).   
 
 31 
 
 
 
Figure 1.5.  The Lol sorting machinery in E. coli and architecture of the cell envelope.  
 LolCDE is an ABC transporter that functions to release lipoproteins destined to the outer 
membrane and creates a water-soluble complex with LolA.  In turn, LolA transfers the 
lipoprotein to LolB, which inserts the lipoprotein into the periplasmic side of the outer 
membrane.  Outer membrane translocation only occurs if there is not an Asp in the +2 position of 
the mature lipoprotein.  If an Asp is in the +2 position, the lipoprotein creates a complex with the 
phospholipid PE that possesses five acyl chains, which fails to interact with LolCDE and the 
lipoprotein is retained in the inner membrane (Tokuda and Matsuyama, 2004).  Lpp contains a 
Ser in the +2 position and is sorted to the outer membrane and bound to peptidoglycan via 
Lys58.  The C-terminus of free-form Lpp is surface exposed (not pictured) (Cowles et al., 2011; 
Bernstein, 2011).  See text for details. 
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Figure 1.6.  The Borrelia cell envelope and lipoprotein sorting.   
The B. burgdorferi proteome contains homologues of all the localization of lipoproteins (Lol) 
machinery with the exception of the outer membrane lipoprotein receptor protein, LolB.  
Presumably, the lipoproteins are anchored into the periplasmic face of the outer membrane by a 
LolB-like protein before an unidentified lipoprotein-specific ‘flippase’ transfers the lipoprotein 
from the periplasmic face of the outer membrane to the surface (Schulze and Zückert, 2006; 
Schulze et al., 2010; Bergström and Zückert 2010).  See text for details.   
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Chapter II. 
Materials and Methods 
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Bacterial Strains and growth conditions   
Borrelia burgdorferi B313 (Sadziene et al., 1993) B31 A3 ospC::kanR (provided by Patti Rosa, 
NIH/NIAID Rocky Mountain Laboratories, Hamilton, MT), B31-A (Bono et al., 2000), B31-A 
ctpA::kanR (provided by Sven Bergström, Umeå University, Umeå, Sweden)(Östberg et al., 
2004), and B31-e2 (provided by B. Stevenson, University of Kentucky, Lexington, KY; (Babb et 
al., 2004) are all derivatives of strain B31 (ATCC 35210).  B313 contains plasmids cp26, cp32-1, 
cp32-2/7, cp32-3, and lp17 (Zückert et al., 1999; Zückert et al., 2004). B31-e2 contains plasmids 
cp26, cp32-1, cp32-3, cp32-4, lp17, lp38 and lp54 (Babb et al., 2004). Using PCR with plasmid-
specific primer sets (Labandeira-Rey and Skare, 2001; Caimano et al., 2004), B31-A and B31-A 
ctpA::kanR were determined to harbor plasmids cp26, cp32-1, cp32-2/7, cp32-3, cp32-9, lp17, 
lp28-1, lp28-2, lp28-3, lp36, lp54, and lp56; B31-A3 ospC::kanR is a low-passage, transformable 
clone lacking lp25 (not shown).  This information is detailed in Table 2.1.  B. burgdorferi were 
cultured in liquid or solid BSK-II medium at 34ºC under a 5% CO2 atmosphere (Barbour, 1984; 
Zückert, 2007).  Selective BSK-II media were supplemented where needed with 200 µg ml-1 of 
kanamycin, 40 µg ml-1 gentamicin, or 50 µg ml-1 of streptomycin (Sigma).  E. coli strains TOP 
10 (Invitrogen) and XL-10 Gold (Stratagene) were used for plasmid construction and 
propagation, and BL21(DE3) pLysS for recombinant protein expression.  Unless noted 
otherwise, E. coli cultures were grown at 37ºC in Lysogeny broth (LB) (Bertani, 2004) or LB 
agar (Difco) supplemented with 30 µg ml-1 of kanamycin, 15 µg ml-1 gentamicin, or 100 µg ml-1 
spectinomycin (Sigma).  
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Site-directed mutagenesis 
 Plasmids carrying mutant genes were constructed either by splicing overlap extension PCR 
(SOE-PCR) (Ho et al., 1989) with Pfx Platinum (Invitrogen) or Phusion Hotstart (New England 
Biolabs) thermostable proofreading DNA polymerases or by following the Quick-Change site-
directed mutagenesis protocol (Stratagene).  Sequences were verified by DNA sequencing 
(ACGT Inc., Wheeling, IL or Northwestern University, Chicago, IL).  The plasmids used are 
shown in Table 2.2.   
  
SDS-PAGE and Immunoblot analysis   
Proteins were separated by sodium dodecyl sulfate-12.5% polyacrylamide gel electrophoresis 
(SDS-PAGE) and visualized by Coomassie blue or silver staining.  For immunoblots, proteins 
were electrophoretically transferred to Immobilon-NC nitrocellulose membranes (Millipore) 
using a Transblot semi-dry transfer cell (Bio-Rad).  Membranes were washed in 20 mM Tris, 
500 mM NaCl, pH 7.5 (TBS).  TBS with 0.05% Tween 20 (TBST) containing 5% dry milk was 
used for membrane blocking and subsequent incubation with primary and secondary antibodies; 
TBST alone was used for the intervening washes.  Antibodies used are detailed in Table 2.2.  
Alkaline phosphatase substrates were 1-Step NBT/NCIB (Pierce) for colorimetric and CDP-Star 
(GE Healthcare Life Sciences) for chemiluminescent detection.  Restore Western blot stripping 
reagent (Pierce) was used to remove bound antibodies from immunoblots to allow for reprobing 
of membranes.  Proteins tagged with a hexahistidine epitope tag were detected directly with a 
nickel-activated HisProbe-HRP conjugate and SuperSignal HRP chemiluminescent detection 
substrate (Pierce) 
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Construction of mutant plasmid library to identify subsurface localization signals 
First, translationally silent restriction endonuclease sites for BsaI and BstBI were engineered into 
plasmids pRJS1009 and pRJS1016 (Schulze and Zückert, 2006) using the QuickChange II XL 
site-directed mutagenesis kit (Stratagene) and oligonucleotide primers (IDT Integrated DNA 
Technologies, Coralville, IA) BsaImut-fwd and –rev and Bstmut-fwd and -rev, respectively 
(Figure 2.1).  OspA codon L10 (CTA) was changed to CTC using primers, and mRFP1 codons 
V15 (GTG) and R16 (CGC) were changed to CTT and CGA, resulting in pOSK1.  Next, a 114-
mer random mutagenesis oligonucleotide, Rmut-oligo, was synthesized and purified by 
polyacrylamide gel electrophoresis (PAGE, Integrated DNA Technologies, Coralville, IA).  In 
Rmut-oligo, the mRFP-1 E4 and D5 codons are replaced by NNK.  K, i.e., G or T in the third 
position allows for any amino acid, but is biased against stop codons.  Only UAG "amber" had to 
be allowed to cover all amino acids.  Rmut-oligo was converted into a double-stranded DNA 
molecule using oligonucleotide Rmut-rev and the large fragment of DNA polymerase I 
(Invitrogen).  The fill-in reaction was terminated using a MinElute reaction cleanup kit (Qiagen).  
pOSK1 and the double-stranded Rmut linker were then both digested with BsaI and BstBI (New 
England Biolabs).  The cut vector was treated with shrimp alkaline Phosphatase (Invitrogen) 
before ligation to the Rmut DNA linker with a Quick Ligation kit (NEB).  Chemically competent 
E. coli Top10 were transformed with approximately 10 ng of the ligation reaction and 
transformants were grown in batch in 500 ml of LB broth for 18 hours at 37°C with aeration.  
Plasmid DNA was then isolated using a Biotech Spin Doctor BAC prep kit (Midwest Scientific) 
following the manufacturer’s protocol.  Borrelia cells were transformed by electroporation with 
2 µg of plasmid DNA using established protocols (Stewart et al., 2001; Samuels, 1995) and 
grown in liquid BSK-II media at 34°C and 5% CO2. 
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Fluorescence activated cell sorting (FACS) 
2x106 spirochetes were harvested as described (Schulze and Zückert, 2006), washed twice with 
phosphate buffered saline containing 5 mM MgCl2 (PBS+Mg), and incubated with a final 
concentration of 50 µg ml-1 proteinase K (Invitrogen) for one hour at room temperature.  Mock-
treated cells were incubated in PBS+Mg only.  Cells were then washed three times with PBS 
containing 0.1% bovine serum albumin (PBS+BSA) and resuspended in 1 ml of PBS+BSA at a 
density of 1 to 1.5x106 cells ml-1.  Spirochetes retaining red fluorescence were then sorted by 
FACS on a BD FACSAria (BD Biosciences) at a flow rate of 200 events s-1 and 55 psi through a 
70 µm nozzle.  Excitation, long pass, and band pass wavelengths were 488 nm, 635 nm, and 695 
+/- 40 nm, respectively.  Upon completion of FACS, the volume of the sorted cells (about 1 ml) 
was immediately adjusted to 12 ml with BSK-II and incubated at 34°C.  The FlowJo program 
suite, version 7.2.2 (Treestar), was used for data analysis. 
 
DNA sequence analysis and identity of subsurface retention signals 
 Spirochetes were counted using a Petroff-Hauser counting chamber, adjusted to 200 cells ml-1, 
plated on solid BSK II media (Zückert, 2007), and incubated at 34°C and 5% CO2.  Individual 
colonies were picked using sterile toothpicks and cultured in 200 µl of BSK-II complete media in 
a sterile 96-well tissue culture plate (Corning).  The mutated ospA-mrfp1 region was amplified 
from 1 µl of 1:10 diluted culture in sterile water using primers Mutscreen-fwd and –rev (Fig. 
3.1).  PCR products were purified using a PCR purification kit (Qiagen) and sequenced (AGCT 
Inc., Wheeling, IL) using primer Mutscreen-seq.  Each sequenced mutant was cultured in liquid 
BSK-II culture for further analysis. 
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Protease accessibility assays 
To assess protein surface exposure by protease accessibility, intact B. burgdorferi cells were 
treated in situ with proteinase K as described (Bunikis and Barbour, 1999; Schulze and Zückert, 
2006).  Briefly, cells were harvested, washed twice in PBS+Mg and treated with 200 µg ml-1 
proteinase K (Invitrogen) or treated with buffer as a control.  To test the sensitivity of proteins to 
trypsin, cells were incubated with 200 µg ml-1 of trypsin (Sigma) as described (Bunikis and 
Barbour, 1999).  To gain access to periplasmic proteins, cells were also treated with 0.1% SDS to 
permeabilize the OM (Sigma; (Jewett et al., 2007)).  All protease reactions were terminated with 
PMSF (Sigma).   
 
Membrane and protein fractionations 
For B. burgdorferi, outer membrane vesicles were isolated and purified by treatment of cells with 
low pH, hypotonic citrate buffer followed by isopycnic sucrose gradient centrifugation as 
described (Skare et al., 1995).  Briefly, late exponential phase B. burgdorferi cells were washed 
in 1× PBS containing 0.1% BSA, resuspended and incubated under vigorous shaking for 2 h in 
25 mM citrate buffer, pH 3.2, containing 0.1% BSA. OMVs and PCs were fractionated by 
ultracentrifugation in a discontinuous gradient of 56%, 42% and 25% (w/w) sucrose in citrate 
buffer using a Beckman L8-80M centrifuge, SW28 rotor and 25×89mm Ultra-Clear 
ultracentrifuge tubes. Fractions were washed and resuspended in 1× PBS containing 1 mM 
PMSF.   
 Membrane proteins were extracted by detergent solubilization using a protocol modified 
from (Brandt et al., 1990) and (Nally and Timoney, 2001). Briefly, harvested B. burgdorferi cells 
were solubilized overnight in ice-cold PBS-Mg containing 2% (v/v) Triton X-114 with rotation 
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at 4°C. Insoluble PC material was removed by centrifugation and the supernatant was phase- 
separated at 37°C for 15 min and centrifuged to obtain the aqueous periplasmic and detergent-
soluble membrane fractions. Both the aqueous and detergent fractions were washed three times 
by addition of ice-cold Triton X-114 to the aqueous phase at 2% final concentration, or ice-cold 
PBS+Mg to detergent phase and phase-separated as above. Proteins were concentrated by 
acetone precipitation. 
 For E. coli, a modified protocol from (Robichon et al., 2005) was followed.  Briefly, A 
1:100 dilution of an overnight culture grown at 37°C in LB containing 30 µg ml-1 kanamycin was 
used to inoculate a 200 ml culture of selective LB broth. After cultivation at 37°C to an OD600 = 
0.8-1.0, cells were pelleted, washed with PBS, and resuspended in 5 ml of 25mM HEPES 
(Sigma) pH 7.4.  Cells were lysed by three passages through a French pressure cell.   The lysate 
was then supplemented with 10 µg ml-1 DNase I (Invitrogen) and pancreatic RNase A (Qiagen) 
then centrifuged for 10 min at 4,000 rpm remove unbroken cells. Membranes were then collected 
by ultracentrifugation at 160,000 × g for 1 h at 4 °C, resuspended and saturated at 60% (w/w) of 
sucrose in 200 µl of 25 mm HEPES (pH 7.4), and then placed at the bottom of an ultracentrifuge 
tube. Steps (600 µl) were created using 56.2, 53.2, 50.2, 47.1, 44.2, 41.2, 38.1, and 35.9% (w/w) 
sucrose solutions, and the tubes were centrifuged in Sw-55Ti swinging bucket rotor (Beckman) 
for 36 h at 230,000 × g at 10 °C. Twenty fractions (250 µl) were collected from the top of the 
tubes and analyzed by SDS-PAGE and immunoblotting.   
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Densitometry and calculations 
Densitometry of Coomassie blue-stained protein bands and Western blot signals acquired with a 
Fuji LAS-4000 fluorescence imager with a linearity of 4 orders of magnitude was done using the 
Image J image analysis software (http://rsb.info.nih.gov/ij/).  The percentage of surface-localized 
protein was calculated using the following formula: % surface = 100 - [(Exp+pK x FlaB–pK) ÷ 
(mExp–pK x FlaB+pK)] x 100, where experimental (Exp) and FlaB indicate the raw Western 
immunoblot densitometry data in absence (–pK) or presence (+pK)  of proteolysis.  Negative % 
surface were set to zero.  The OM/PC distribution ratio using the following formula: ratioOM/PC = 
(mExpOM ÷ mExpPC) ÷ [(OspAOM ÷ OspAPC) – (OppAIVOM ÷ OppAIVPC)], where experimental 
(Exp), OspA and OppAIV represent the raw Western immunoblot densitometry data in either the 
OM or PC fractions.  Genomic B. burgdorferi strain B31 (GenBank Accession # NC_001318) 
codon usage data were acquired from the Georgia Tech Codon Usage Database 
(http://exon.gatech.edu/GeneMark/metagenome/CodonUsageDatabase/). 
 
In situ crosslinking   
Assays were carried out as described (Bunikis and Barbour, 1999; Zückert et al., 2001).  Briefly, 
cells were grown to a density of ~5x107 cells ml-1, harvested, and washed twice in PBS+Mg.  
Proteins were crosslinked with 1% (v/v) formaldehyde (Sigma) at room temperature for 30 
minutes.  Cells were washed twice with PBS+Mg and resuspended in SDS-PAGE loading dye 
with 50 mM DTT and incubated at 37ºC for 10 minutes. 
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Salp15 overlay assay 
The Ixodes scapularis Salp15 overlay assay was performed as described (Ramamoorthi et al., 
2005).  Briefly, B. burgdorferi lysates separated by SDS-PAGE and blotted to a nitrocellulose 
membrane were first incubated in blocking buffer (1% BSA, 3% dry milk in Tris Buffered Saline 
0.05% Tween-20) at 4ºC overnight.  Then, the membrane was incubated with 1 µg ml-1 of 
recombinant, V5-epitope-tagged I. scapularius Salp15 (a gift from E. Fikrig, Yale University, 
New Haven, CT) in blocking buffer.  The membrane was then washed, incubated with a 1:2000 
dilution of anti-V5 HRP conjugated antibody (Invitrogen), washed again, and developed using 
the SuperSignal HRP chemiluminescent detection kit (Pierce). 
 
Immunoprecipitation 
 2.5x109 B. burgdorferi cells grown to late exponential phase (5x107 cells ml-1) were harvested, 
washed three times with PBS+Mg and lysed in IGEPAL lysis buffer (150mM NaCl, 50mM Tris 
pH 8.0, 1% IGEPAL, 1mM PMSF) or RIPA lysis buffer (300mM NaCl, 50mM Tris pH 7.4, 1%  
TritonX-100, 0.1% SDS, 1% deoxycholic acid, 1mM PMSF).  After preclearing by incubation 
with protein A beads (GE) for one hour at 4ºC with end-over-end rotation, the lysate was 
incubated with 10 µg of purified anti-OspC monoclonal antibody (Gilmore and Mbow, 1999; 
Mbow et al., 1999), a gift from R. Gilmore, CDC-Fort Collins, CO), anti-FLAG monoclonal 
antibody (Sigma), or anti-HA monoclonal antibody (Sigma) for one hour at 4ºC.  Protein A 
beads were added to the lysate at 4ºC for one hour.  The beads were washed three times with 
IGEPAL or RIPA lysis buffer and once with 50mM Tris (pH 8.0).  Beads were incubated in SDS 
PAGE loading dye with 50 mM DTT, boiled, and the supernatant analyzed by SDS-PAGE and 
immunoblotting. 
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Purification of recombinant OspC   
DNA fragments corresponding to N-terminally truncated, soluble OspC were amplified by PCR 
from pOSK307 (Table 2.3) with oligonucleotide primers including 5’ NdeI and 3' BamHI 
extensions.  The three different 5' oligonucleotides primers placed the N20, N31, and V37 
codons immediately after the fMet start codon, respectively.  The PCR products were gel-
purified, digested with NdeI and BamHI and ligated with a pET29b (Novagen) backbone 
previously linearized with NdeI and BamHI.  The resulting expression plasmids were sequenced 
and used to transform BL21 (DE3) pLysS (Novagen).  A 1:100 dilution of an overnight culture 
grown at 37°C in LB containing 30 µg ml-1 kanamycin and 100 µg ml-1 chloramphenicol was 
used to inoculate a larger culture of selective Terrific Broth.  After cultivation at 37°C to an 
OD545 = 0.3-0.4, recombinant protein expression was induced with 1 mM of isopropyl β-D-1-
thiogalactopyranoside (Invitrogen) for 5 hours at 30°C.  Cells were harvested and lysed by 
sonication, and cell debris was removed by centrifugation at 12,000 x g for 20 min at 4°C.  The 
cell-free lysate was then applied to a Talon cobalt column (Clontech) equilibrated with loading 
buffer (300 mM NaCl, 50mM NaPO4  pH 7.0), and washed with loading buffer containing 10 
mM imidazole.  Recombinant OspC at a purity of about 90% was eluted in buffer containing 100 
mM imidazole (Sigma).  For further purification, we followed the protocol of (Kumaran et al., 
2001) with some modifications.  The cobalt column eluate was dialyzed twice against 20mM 
NaPO4, 5mM NaCl, pH 7.7, and then applied to a Hi-Trap Q anion exchange column (GE 
Healthcare).  The flow-through containing OspC was dialyzed twice against 10mM NaPO4, 5 
mM NaCl, pH 6.0 and applied to a Hi-Trap SP cation exchange column (GE Healthcare).  OspC 
eluted quantitatively at 500mM NaCl at a purity of about 98%, was dialyzed twice against 10mM 
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NaPO4 buffer, pH 7.0, and concentrated using Amicon Ultra centrifugal filters with a 3 kDa 
cutoff (Millipore).  Protein concentrations were determined by Bradford assay (Bio-Rad). 
 
Purification of recombinant OspA   
DNA fragments corresponding to N-terminally truncated, soluble OspA were amplified by PCR 
from pCSY1000 with oligonucleotide primers including 5’ NdeI and 3' BamHI extensions.  The 
two different 5' oligonucleotides primers placed the A17 and S29 codons immediately after the 
fMet start codon, respectively.  The PCR products were gel-purified, digested with NdeI and 
BamHI and ligated with a pET29b (Novagen) backbone previously linearized with NdeI and 
BamHI.  The resulting expression plasmids were sequenced and used to transform BL21(DE3) 
pLysS (Novagen).  A 1:100 dilution of an overnight culture grown at 37°C in LB containing 30 
µg ml-1 kanamycin and 100 µg ml-1 chloramphenicol was used to inoculate a larger culture of 
selective Terrific Broth.  After cultivation at 37°C to an OD545 = 0.3-0.4, recombinant protein 
expression was induced with 1 mM of isopropyl β-D-1-thiogalactopyranoside (Invitrogen) for 5 
hours at 30°C.  Cells were harvested and lysed by sonication, and cell debris was removed by 
centrifugation at 12,000 x g for 20 min at 4°C.  The cell-free lysate was then applied to a Talon 
cobalt column (Clontech) equilibrated with loading buffer (300 mM NaCl, 50mM NaPO4  pH 
7.0), and washed with loading buffer containing 10 mM imidazole.  Recombinant OspA at a 
purity of about 95% was eluted in buffer containing 100 mM imidazole (Sigma).  OspA was 
dialyzed twice against 10mM NaPO4 buffer, pH 7.0, and concentrated using Amicon Ultra 
centrifugal filters with a 3 kDa cutoff (Millipore).  Protein concentrations were determined by 
Bradford assay (Bio-Rad). 
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Circular dichroism measurements and analysis of thermal unfolding   
Circular dichroism measurements were performed using an upgraded Jasco-720 
spectropolarimeter (Japan Spectroscopic Company, Tokyo).  10-20 scans were recorded between 
190 and 260 nm with a 1 nm step at +20°C, using a 1 mm optical path cuvette. protein 
concentrations of 3-5 µM, determined by UV absorbance measurements using a coefficient of 
molar extinction of 2400 M-1*cm-1, were used in the experiments.  All spectra were corrected for 
background.  Temperature dependencies of unfolding were measured at 222 nm (rOspC) or 212 
nm (OspA) with 1 degree/min scan rate.  Thermal unfolding was analyzed as described (Eftink et 
al., 1994) to obtain transition temperature (Tm) and enthalpy (ΔH). The free energy (ΔG) 
stabilizing native structure at room temperature was estimated using standard assumptions on the 
value of heat capacity according to (Robertson and Murphy, 1997). 
 
RNA extraction and Northern Blotting 
Total RNA was isolated from 14-ml cultures at a density of ~5x107 spirochetes/ml using an 
RNeasy Mini Kit (Qiagen). Prior to isolation, the RNAs were fixed using RNA Protect reagent 
(Qiagen). RNA concentrations were measured using a NanoDrop 1000 spectrophotometer 
(Thermo Scientific). Total RNA (2.0 µg) was fractionated in a 1.2% formaldehyde-agarose gel 
and transferred to an Immobilon-NY membrane (Millipore) by upward capillary transfer 
(Sambrook and William Russell, 2001). RNA ladders (0.24 to 9.5 kb; Invitrogen) served as size 
standards. A DNA probe was generated by PCR using primer pairs complementary to the ospC 
and vsp1 coding regions and pOSK200 and pVsp1 as templates, respectively (Table 2.3). Probe 
labeling and Northern blot hybridizations were performed using the Gene Images AlkPhos Direct 
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Labeling and Detection System with CDP-Star (GE Healthcare) according to the manufacturer’s 
instructions. A Fujifilm LAS-4000 Luminescent Image Analyzer was used for data acquisition 
and analysis. 
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Table 2.1. Bacterial Strains Used in this Study 
Strain    Description    Source/Reference 
Strains 
 Borrelia burgdorferi 
 B313   Clone of B31 ATCC 35210 (cp26, cp32-1,   (Sadziene et al., 1995) 
    cp32-2/7, cp32-3 and lp17). 
B31e2   Clone of B31 ATCC 35210 (cp26, cp32-1  (Babb et al., 2004) 
    cp32-3, cp32-4, lp17, lp38 and lp54). 
B31-A   Clone of B31 ATCC 35210 (cp26, cp32-1,   (Bono et al., 2000) 
cp32-2/7, cp32-3, cp32-9, lp17, lp28-1,  
lp28-2, lp28-3, lp36, lp54, lp56). 
 B31-A (ΔctpA)  C-terminal protease A (ctpA) knockout,   (Östberg et al., 2004) 
PflaB-kan insertion in ctpA (plasmid content is 
identical to B31-A)     
 B31-A3 (ΔospC)  Outer surface protein C (ospC) knockout,  (K. Tilly and P. Rosa 
PflaB-kan insertion in ospC (lp25-)    unpublished) 
  
 
 Escherichia coli 
 Top10   F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 Invitrogen 
    ΔlacX74 recA1 araD139 Δ(ara leu) 7697 galU 
    galK rpsL (StrR) endA1 nupG 
 XL-10 Gold  Tetr D(mcrA)183 D(mcrCB-hsdSMR-mrr)173 Stratagene 
    endA1 supE44 thi-1 recA1 gyrA96 relA1 lac The 
    [F’ proAB lacIqZDM15 Tn10 (Tetr) Amy Camr 
 BL21(DE3) pLysS F- ompT hsdSB(rB- mB-) gal dcm λ(DE3) tonA  Novagen 
pLysS (Camr) 
 
 
 
 
Table 2.2. Antibodies Used in this Study 
Antibody   Source Animal Dilution Source/Reference 
anti-OspA (monoclonal)  Mouse   1:50  (Barbour et al., 1983) 
anti-OspC (monoclonal)  Mouse   1:50  (Gilmore and Mbow, 1999) 
anti-OspC (polyclonal)  Rabbit   1:200  (Gilmore and Mbow, 1999) 
anti-Vsp1 (monoclonal)  Mouse   1:25  Alan Barbour 
anti-Vsp1 (polyclonal)  Rabbit   1:500  Alan Barbour 
anti-Vsp2 (polyclonal)  Rabbit   1:500  Alan Barbour 
anti-His Tag (monoclonal)  Mouse   1:500  Sigma 
anti-HA Tag (monoclonal) Mouse   1:500  Sigma 
anti-FLAG Tag (monoclonal) Mouse   1:10,000 Sigma 
anti-CtpA (polyclonal)  Rabbit   1:100  (Östberg et al., 2004) 
anti-OppAIV (polyclonal)  Rabbit   1:100  Patricia Rosa (Bono et al., 1998) 
anti-mRFP1 (polyclonal)  Rabbit   1:5000  Patrick Viollier (Chen et al., 2005) 
anti-FlaB (polyclonal)  Rabbit   1:1000  Darrin Akins (Akins et al., 1999) 
anti-FlaB (polyclonal)  Rat   1:2000  Melissa Caimano 
anti-Mouse IgG (H+L)*  Rabbit   1:30,000 Sigma 
anti-Rabbit IgG (H+L)*  Goat   1:30,000  Sigma 
anti-Rat IgG(γ-chain specific)* Goat   1:30,000  Sigma 
.    
*Conjugated to Alkaline Phosphatase. 
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Table 2.3. Plasmids Used in this Study 
Plasmid  Description     Source/Reference 
pET29b   Expression vector for protein purification  Novagen 
pVsp1   pBSV2:PflaB-vsp1    (Zückert et al., 2001) 
pBSV2   Shuttle vector (KanR)    (Stewart et al., 2001) 
pKFSS1   Shuttle vector (StrR)    (Frank et al., 2003) 
pBSV2.2  Shuttle vector (GmR)    (Elias et al., 2002) 
pBSVG+ctpA  pBSV2G:ctpA     (Östberg et al., 2004) 
pRJS1091  pBSV2:PflaBospA22-mRFPΔ4   This study 
pRJS1090  pBSV2:PflaBospA25-mRFPΔ4   This study 
pOSK240  pBSV2:PflaBospC29-mRFPΔ4   This study 
pOSK258  pBSV2:PflaBospC30-mRFPΔ4   This study 
pOSK257  pBSV2:PflaBvsp1-31-mRFPΔ4   This study 
pOSK256  pBSV2:PflaBvsp1-32-mRFPΔ4   This study 
pOSK200  pKFSS1:PflaB-ospC    This study 
pOSK273  pKFSS1:PflaBospC(ΔN20-A30)   This study 
pOSK274  pKFSS1:PflaBospC(ΔN31-N41)   This study 
pOSK299  pKFSS1:PflaBospC(ΔS22)   This study 
pOSK300  pKFSS1:PflaBospC(ΔN21)   This study 
pOSK287  pKFSS1:PflaBospC(ΔN20-S22)   This study 
pOSK288  pKFSS1:PflaBospC(ΔG23-D25)   This study 
pOSK301  pKFSS1:PflaBospC(ΔN21-S22)   This study 
pOSK294  pKFSS1:PflaBospC(ΔA33-N41)   This study 
pOSK302  pKFSS1:PflaBospC(Δ34-N41)   This study 
pOSK309  pBSV2:PflaBospC(Ala)21-22   This study 
pOSK310  pBSV2:PflaBospC(Gly)21-22   This study 
pOSK268  pBSV2:PflaBvsp1(ΔN20-S25)   This study 
pOSK269  pBSV2:PflaBvsp1(ΔG23-D28)   This study 
pOSK262  pBSV2:PflaBvsp1(ΔN20-S22)   This study 
pOSK263  pBSV2:PflaBvsp1(ΔG23-S25)   This study 
pOSK275  pBSV2:PflaBvsp1(ΔN20-A32)   This study 
pOSK276  pBSV2:PflaBvsp1(ΔK33-I39)   This study 
pOSK279  pBSV2:PflaBvsp1(ΔN21-S25)   This study 
pOSK278  pBSV2:PflaBvsp1(ΔS22-S25)   This study 
pOSK284  pBSV2:PflaBvsp1(ΔN20-G23)   This study 
pOSK285  pBSV2:PflaBvsp1(ΔN20-T24)   This study 
pOSK289  pBSV2:PflaBvsp1(ΔS22-S25)   This study 
pOSK291  pBSV2:PflaBvsp1(ΔN21-G23)   This study 
pOSK292  pBSV2:PflaBvsp1(ΔS22-T24)   This study 
pOSK313  pBSV2:PflaBvsp1(ΔN20-S25)P26A  This study 
pOSK351  pET29b:pT7ospCN20-His    This study  
pOSK352  pET29b:pT7ospCN31-His    This study 
pOSK353  pET29b:pT7ospCV37-His    This study 
pOSK248  pBSV2:PflaB-vsp1D60K/D87K/D150K  This study 
pOSK307  pKFSS1:PflaB-ospC-linker-his tag   This study 
pOSK312  pKFSS1:PflaB-ospC-(ΔS22)-linker-his tag  This study 
pOSK326  pKFSS1:PflaB-ospC-A204X   This study 
pOSK260  pKFSS1:PflaB-ospC-linker   This study 
pOSK277  pKFSS1:PflaB-ospC-internal his tag  This study 
pOSK308  pKFSS1:PflaB-ospC-L2-FLAG tag   This study 
pOSK308.1  pBSV2.2:PflaB-ospC-L2-FLAG tag  This study 
pOSK374  pKFSS1:PflaB-ospC(Δ2 0-30) L2-HA tag  This study 
pOSK384  pET29b:pT7ospA-A17-His   This study 
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pOSK385  pET29b:pT7ospA-S29-His   This study   
pOSK101  pBSV2:PflaB-lpp-His    This study 
pOSK102  pBSV2:PflaB-lpp(ΔK58)-His   This study 
pOSK103  pBSV2:PflaB-lpp(N22A/S23A/S24A)-His  This study 
pOSK104  pBSV2:PflaB-lpp(ΩKQNV/N22)-His  This study 
pOSK260  pKFSS1:PflaB-ospC(Δtether)   This study 
pOSK267  pBSV2:PflaB-vsp1(Δtether)   This study 
pCSY1000  pBSV2:pFlaB-ospA-link-his   Shyiong Chen 
pOSK344  pBSV2:pFlaB-vsp1D60K/D87K/D150K-HA-L5 This study 
pOSK208  pBSV2:pFlaB-vsp2-FLAG-L5   This study 
pOSK208.1  pBSV2.2:pFlaB-vsp2-FLAG-L5   This study 
pOSK364  pBSV2:pFlaB-vsp1-HA-L5   This study 
pOSK3   pBSV2:pFlaB-ospA20mRFP1(E4ND5N)(pRJS1016 based) (Kumru et al., 2010) 
pOSK4   pBSV2:pFlaB-ospA20mRFP1(E4ND5N)(pRJS1009 based) (Kumru et al., 2010) 
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Chapter III.  
Development and validation of a FACS-based lipoprotein localization screen 
in the Lyme disease spirochete Borrelia burgdorferi 
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Abstract 
 
Surface lipoproteins of Borrelia burgdorferi, the causative agent of Lyme borreliosis, are major 
virulence factors in the establishment and persistence of infection within the tick vector and the 
human host.  We previously showed that B. burgdorferi lipoproteins are transported to the 
spirochetal surface by default and are not subject to the ‘+2’ sorting rule.  Yet, we identified an 
N-proximal tandem negative charge (Asp-Glu) in a fusion of outer surface protein A to 
monomeric red fluorescent protein 1 (OspA20:mRFP1), which served as an inner membrane 
retention signal.  Here, we asked whether other amino acid combinations could function as 
subsurface localization signals in the same context.  Random mutagenesis was performed on the 
OspA20:mRFP1 Asp-Glu codons to generate a library of 400 potential amino acid combinations.  
In situ proteolysis of intact Borrelia cells combined with fluorescence activated cell sorting 
(FACS) was then used to screen for viable spirochetes expressing subsurface OspA:mRFP1 
fusions.  Analysis of 104 individual clones identified a total of 44 distinct mutants.  Only 15 of 
these mutants were predominantly surface-localized, which validated this fluorescence-based 
screen for further application.  An Asp-Glu mutant identical to OspA19:mRFP1 was re-isolated 
and remained the only one restricted to the inner membrane; all other mutants were released 
from the inner membrane, but impaired to different degrees in translocating the outer membrane.  
This suggests a rather specific inner membrane retention mechanism involving N-proximal 
negative charge patches in this model B. burgdorferi lipoprotein system. 
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Introduction 
Temporally and spatially regulated expression of surface-exposed lipoproteins such as 
OspA, OspC and VlsE enables the Lyme disease spirochete Borrelia burgdorferi to adapt to 
changing environmental conditions and allows for maintenance of the organism within an 
enzootic tick-mammal cycle (Pal et al., 2000; Grimm et al., 2004; Bankhead and Chaconas, 
2007).  Yet, we are only beginning to understand the factors that govern accurate localization of 
these important virulence factors to the bacterial cell surface, thereby generating the pathogen-
host interface.  In prior studies, we demonstrated a role for the ‘tether’ region, i.e., the disordered 
N-terminus of these lipoproteins in the localization process.  Fusion of the first five residues of 
the mature outer surface lipoprotein OspA was sufficient to target the red fluorescent reporter 
protein mRFP1 to the surface of the Borrelia cell (Schulze and Zückert, 2006).  The same study 
also revealed that previously identified lipoprotein sorting rules identified in Enterobacteriaceae 
and Pseudomonas  (Yamaguchi et al., 1988; Silva-Herzog et al., 2008; Narita and Tokuda, 2007) 
did not apply to Borrelia lipoproteins.  An alignment of B. burgdorferi lipoprotein tether peptide 
sequences failed to reveal any apparent primary sequence conservation.  Trafficking may thus 
depend on specific biophysical properties of the tether polypeptide such as hydrophobicity, 
charge, or secondary structure propensity, rather than strict amino acid identity alone (Haake, 
2000; Cullen 2004). 
In the present study, we designed and tested an experimental approach that might help in 
elucidating these still obscure sorting signals.  Based on an existing OspA tether-mRFP1 fusion 
with a characterized inner membrane (IM) release defect, we generated a partially randomized 
fluorescent lipopeptide library in B. burgdorferi.  A fluorescence-activated cell sorting (FACS)-
based screen was then used to enrich for mutants localizing to the periplasm.  Our results 
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indicate that this approach can become an important tool to detect general patterns in peptides 
mediating surface or subsurface localization. 
 
Results & Discussion 
Design of a fluorescence-based screen for lipoprotein localization in B. burgdorferi.  
In our recent studies, the use of fusions of red fluorescent mRFP1 to various N-terminal 
fragments and point mutants of B. burgdorferi surface lipoprotein OspA led to an initial 
assessment of the sequence requirements for proper surface display (Schulze and Zückert, 2006; 
Schulze et al., 2010).  To complement this step-wise, targeted mutagenesis approach, we set out 
to develop a random mutagenesis screen.  Our starting point was a previously described OspA-
mRFP1 fusion, OspA20:mRFP1, which could be redirected from the IM to the bacterial surface 
by mutagenesis of two adjacent negatively charged amino acids (Glu-Asp) to two Ala residues.  
We therefore hypothesized that (i) additional mutagenesis in this OspA20:mRFP1 dipeptide 
would reveal the specificity of periplasmic, particularly IM retention signals in this model 
lipoprotein, and that (ii) periplasmically localized fusion protein mutants could be enriched by a 
combination of in situ surface proteolysis and fluorescence-activated cell sorting (FACS).  The 
approach is detailed in Chapter II and shown in Fig 3.1. 
 Two plasmid libraries were generated from two different starting materials, pRJS1009 
and pRJS1016 (Schulze and Zückert, 2006).  pRJS1009 carried a fusion of the full-length signal 
peptide and tether of OspA to mRFP1 (OspA28:mRFP1), which was targeted to the bacterial 
surface.  In pRJS1016, the OspA tether sequence was truncated to 4 amino acids 
(OspA20:mRFP1), which led to significant retention of the fusion in the inner spirochetal 
membrane.  In both plasmids, a fragment containing the 5' ospA:mrfp1 sequence was swapped 
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for a DNA fragment randomized at the Glu-Asp codons.  After library expansion in E. coli and 
electroporation of B. burgdorferi, transformants were grown in liquid medium selecting for the 
library plasmids.  To eliminate any non-expressers, we subjected the populations to a first round 
of FACS, collecting only cells with a clear red fluorescent signal (not shown).  Gating was 
determined by plotting logs of forward scatter (FSC) versus side scatter (SSC) as described 
(Whetstine et al., 2009) (Fig. 3.2).  After presorting, cells were allowed to recover in liquid BSK-
II medium and then subjected to proteolytic shaving using proteinase K.  We surmised that 
treated cells would remain fluorescent only if they expressed a subsurface mutant of the 
OspA:mRFP1 fusion. 
 
Genotypic and phenotypic analysis of pre- and post-sorting cell populations.   
Compared to mock-treated cells, the fluorescent population post-treatment decreased for both 
libraries, suggesting that proteolytic shaving indeed resulted in a reduction of surface-associated 
fluorescence.  Interestingly, the reduction was more significant in the pRJS1009-based library 
(from 50% to 7%) than the pRJS1016-based library (from 82% to 64%) (Fig. 2).  We initially 
attributed this to the potential of bleed-through of the original plasmid in the pRJS1016-derived 
library.  Yet, further analysis showed that this effect was negligible as only three Glu-Asp clones 
were recovered post-sorting (see below and Fig. 3.3). 
 A total of 172 random clones, 38 from an unsorted population and 134 from a sorted 
population, were analyzed by DNA sequencing.  63 mutants were identified, 8 being unique to 
the unsorted population, 40 unique to the sorted population, and 15 common to both populations.  
Within the sorted population, the majority of the mutants (40 out of 55, i.e., 73%) were 
recovered repeatedly, e.g. 11 times for Ser-Gly (Fig. 3.3).  This suggested that we were 
 54 
approaching saturation in this experimental setting.  As predicted, sorting for fluorescent cells 
significantly selected against the presence of non-expressing cells:  the incidence of "amber" 
stops within the two mutated codons was reduced 18-fold, from 5 clones in the unsorted to 1 in 
the sorted population. 
 We randomly chose 93 clones from the sorted population for further analysis.  This 
cohort covered 43 individual mutants, 11 of which were also identified in the presorted 
population (Fig. 3.3).  The mutants were assessed for (i) protein levels and (ii) protein 
localization within the spirochetal cell envelope by in situ proteolysis and membrane 
fractionation.  The observed protein levels provided a measure of protein stability in vivo, as an 
identical promoter drove expression of all mutant proteins and no correlation between the wild 
type genomic frequency of the introduced codons and protein levels was observed. 
 For OspA:mRFP1 fusion lipoprotein stability analysis, B. burgdorferi whole cell lysates 
were probed by Western immunoblot analysis using polyclonal antisera against mRFP1 and FlaB 
(Fig. 4).  FlaB served as a loading control.  The signals from the OspA:mRFP1 fusion proteins 
were quantified by densitometry of digital fluorometric images and normalized to the FlaB 
signals.  All experiments were done in triplicate.  Fig. 3.4 shows a representative dataset.  The 
signals from OspA20:mRFP1 (labeled as ED) on each blot were used to normalize between 
individual replicates.  Expression/in vivo stability levels were calculated in percent compared to 
OspA28:mRFP1.  Surface localization of the OspA:mRFP1 mutants was assessed by proteolytic 
shaving with proteinase K followed by Western immunoblotting (Fig. 3.5).  OspA served as a 
surface control while FlaB served as both a loading and periplasmic control.  Accordingly, 
densitometry data were normalized to both OspA and FlaB signals.  Localization of proteins to 
the IM or OM was assessed by Western immunoblots of PC and OM membrane fractions, using 
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OspA and OppAIV as membrane-specific controls and normalization standards (Fig. 3.6).  The 
specific formulas used to calculate both the percentage of surface-localized protein and the 
OM/PC distribution ratios are described in Chapter II. 
 
Classification of phenotypes.   
Based on the in situ proteolysis assay data, the characterized 43 mutant lipoproteins were 
classified according to their surface exposure phenotype (Fig. 3.3 and Table 3.1): 14 mutants or 
31 clones were grouped as predominantly surface-exposed (class +++), 13 mutants or 42 clones 
had an intermediate phenotype (class ++), and 10 mutants or 22 clones localized largely to a 
subsurface compartment (+).  6 mutants represented by 19 clones were indistinguishable in their 
proteinase K accessibility phenotype from the original OspA20:mRFP1ED fusion (class –).  
Although we observed a continuum of phenotypes from IM-retained to surface-localized 
lipoprotein mutants, there was an appreciable enrichment of subsurface phenotypes in the sorted 
population (Fig. 3.3).  Quantifying this shift towards periplasmic localization, the median surface 
percentage dropped from 54% in the unsorted population to 35% in the sorted population (Fig. 
3B).  The median expression levels and OM/PC ratios were 34% and 0.7 for both the unsorted 
and sorted populations.  This indicated that the screen did not exert a pleiotropic, but rather a 
specific and intended selective pressure on the surface phenotype. 
 Surface exposure of lipoproteins in diderm bacteria can be affected by defects in either 
the release from the bacterial IM or a defect in translocation through the OM.  To our surprise, 
most mutants, including the newly identified class – and + mutants localized in significant ratios 
to the OM (Fig. 3.3A and Table 3.1).  One standout mutant in that respect is OspA20:mRFP1KR: 
The fusion protein fractionated to the OM comparable to the surface-exposed OspA28:mRFP1, 
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but 99% of the total protein was protected from proteinase K.  This indicated that this and most 
other mutant proteins were significantly impaired in "flipping" through the OM.  Two aspects of 
this finding are particularly intriguing.  First, we recently observed a similar predominance of 
OM translocation defects when disrupting a Val-Ser-Ser-Leu tetrapeptide within the tether of 
otherwise wild type OspA.  These defects were overcome when the mutant OspA tethers were 
fused to mRFP1, which contains a similar N-terminal Ala-Ser-Ser-Glu tetrapeptide (Schulze and 
Zückert, 2006; Schulze et al., 2010).  The mutations introduced in this study tangentially affect 
this mRFP1-derived tetrapeptide by altering the Glu residue, with similar results.  For example, 
the introduction of Gly residues as in the GG mutant led to a defect while the previously 
described replacement by two Ala residues did not (Schulze and Zückert, 2006).  This supports 
our earlier speculation that the mRFP1 tetrapeptide could functionally offset an OspA tether 
defect (Schulze et al., 2010).  Second, the original OspA20:mRFP1ED retains the most profound 
IM-release defect phenotype.  The Cys-Lys mutant, although comparable in membrane 
localization, is significantly less stable in vivo than OspA20:mRFP1ED.  Confirming our earlier 
site-directed mutagenesis data (Schulze and Zückert, 2006), single negative charges as in the 
Asp-Tyr or Glu-Leu mutants were insufficient to quantitatively restrict a lipoprotein to the 
borrelial IM.  Therefore, small patches of negative charges continue as the only identified IM 
retention signal for lipoproteins expressed in Borrelia cells, albeit in an artificial model 
lipoprotein setting.  Further studies will be needed to identify IM retention signals of natural B. 
burgdorferi lipoproteins such as OppAIV (Schulze and Zückert, 2006; Bono et al., 1998). 
 With the exception of the Gly-Ser and Gly-Val substitutions, most mutants were detected 
at significantly lower levels than both OspA28:mRFP1 and OspA20:mRFP1 (Figs. 3.3A and 
3.4), despite being expressed from an identical promoter.  Interestingly, this phenotype tended to 
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cluster with class +++ surface-localized proteins, e.g. OspA20:mRFP1VR or OspA20:mRFP1WI 
(Fig. 3.3 and Table 3.2).  Based on structural data on the mRFP1 parent molecule DsRed, the 
mutated residues coincide with the transition from the fusion protein's flexible tether to the 
structurally confined red fluorescent protein β-barrel (Yarbrough et al., 2001).  Amino acid 
substitutions, particularly with large bulky amino acids such as Trp or Phe therefore may 
compromise the protein fold.  Based on our recent discovery that translocation of OspA through 
the borrelial OM requires an unfolded conformation (Schulze et al., 2010), we propose that the 
structural instability of mutants contributes to their ultimate surface localization. 
 
Conclusions 
 
Since their inception, fluorescence-based analytical and preparative methods such as flow 
cytometry (FCT) and FACS have reached beyond the realm of immunology.  FCT already has 
seen several applications in spirochetal systems, predominantly in deciphering gene regulation 
mechanisms (Whetstine et al., 2009; Eggers et al., 2006; Srivastava and de Silva, 2008) but also 
in probing membrane characteristics (Cox and Radolf, 2001).  Various FACS-based methods 
such as differential fluorescence induction (DFI; ref (Valdivia, 1997)) have been used in 
different bacterial systems to identify virulence factors important for different pathogenic 
processes such as invasion and intracellular survival (reviewed in (Rediers et al., 2008)) Building 
on the earlier development of recombinant DNA technology (Stewart et al., 2001) and 
fluorescent reporter genes (Schulze and Zückert, 2006; Carroll et al., 2003; Campbell et al., 
2002) this study expands the application of FACS to the study of protein transport mechanisms.  
Similar FACS-based approaches are perceivable to study secretion of other microbial proteins 
localizing to the host-pathogen interface.  The demonstrated ability to sort live B. burgdorferi 
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cells for a particular fluorescent phenotype also opens the door to DFI studies, i.e., the trapping 
of promoters that are active during different stages in the complex multi-host life cycle of this 
medically important spirochete. 
 59 
 
 60 
 
Figure 3.1.  Screening strategy for subsurface OspA:mRFP1 fusions.  A random mutagenesis 
oligo was synthesized to change mRFP1 codons E4 and D5 in OspA20:mRFP1 to any amino 
acid, with a bias against stop codons (except for amber UAG, see text).  The oligo was converted 
to a double-stranded linker and ligated with a shuttle vector carrying the 5' and 3' portions of the 
OspA20:mRFP1 fusion gene.  The resulting library was amplified in E. coli and used to 
transform B. burgdorferi.  A presorted population of red fluorescent spirochetes was incubated 
with proteinase K, washed, and sorted again for red fluorescence.  Clones grown from individual 
colonies were grown in 96-well plates and subjected to a confirmatory in situ proteolysis assay.  
PCR and DNA sequence analysis revealed the mutant genotypes.  Numbered arrows indicate 
specific oligonucleotides used.  For details, see the Chapter II. 
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Figure 3.2.  FACS plots of OspA:mRFP1 mutant populations.  Both pRJS1009- and 
pRJS1016-based B. burgdorferi libraries were assayed.  The two panels to the left indicate the 
gating used.  Forward scatter (FSC) is plotted against side scatter (SSC).  The percentage of 
events, i.e., cells inside the gated population (shaded rectangles) is indicated.  The four panels to 
the right show the distribution of presorted, i.e., OspA:mRFP1-expressing fluorescent cells upon 
treatment with proteinase K.  Mock treated cells were incubated in buffer only.  Fluorescence 
measured via a Texas Red filter is plotted against number of events, i.e., cells.  The vertical line 
indicates the cut-off fluorescence for sorting.  The percentage of events within the fluorescent 
population is indicated. 
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Figure 3.3. Composite phenotypes of lipoprotein mutants.   
(A) Expression, surface exposure and membrane fraction ratio values are plotted for each of the 
43 identified mutants, including OspA20:mRFP1 (ED), as well as the OspA28:mRFP1 control 
are plotted.  Data were derived from independent duplicate or triplicate Western immunoblot 
experiments.  Representative data are shown in Figs. 3.4, 3.5 and 3.6.  Numerical data are listed 
in Table 3.5.  Y-axis ranges were 0-100% for expression/stability levels (yellow diamonds) and 
surface exposure (red triangles), and 0 to 1.0 for the OM/PC ratio (blue squares).  Data points 
with asterisks (*) lay beyond the y-axis ranges (Table 3.1).  Mutant-specific amino acid 
sequences are listed in single letter code on the x-axis.  n indicates the number of times a 
particular mutant was isolated from the unsorted (pre) and sorted (post) population.  Unanalyzed 
mutants are listed in Table 3.1.  (B) Boxplots of surface percentage values of the unsorted (pre) 
and sorted (post) populations.  For each dataset, the box outlines the first and third quartiles, the 
horizontal red line indicates the median, the cross (+) denotes the mean, and the vertical lines 
extend to the minimum and maximum values. 
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Figure 3.4. Phenotypical analysis of select OspA:mRFP1 fusion mutants.  
Representative Western blots of select mutants are shown (Figures 3.5 and 3.6 for full data set). 
Mutant-specific amino acid sequences are listed in single letter code above the blots.  
OspA28:mRFP1 and OspA20:mRFP1 (ED) were included as controls. (A) Protein expression 
and protease accessibility. Whole cell lysates of B. burgdorferi expressing mutant OspA:mRFP1 
fusions from an identical PflaB promoter (Figure 3.1) were obtained before (-) or after (+) in situ 
treatment with proteinase K (pK). A polyclonal antiserum against mRFP1 was used to detect the 
OspA:mRFP1 fusions. Constitutively expressed periplasmic FlaB was used as a control for 
loading (to normalize signals within samples) as well as for subsurface localization (negative 
control). OspA served as a surface control. Untreated (-pK) samples were used to assess protein 
expression/in vivo stability of OspA:mRFP1 fusions. (B) Distribution of proteins to inner or 
outer membranes. Protoplasmic cylinder (PC) and outer membrane vesicle (OM) fractions from 
B. burgdorferi expressing mutant OspA:mRFP1 fusions were probed with a polyclonal antiserum 
against mRFP1 to detect the OspA:mRFP1 fusions. IM-localized lipoprotein OppAIV was used 
as a PC-specific control. Surface lipoprotein OspA was used as an outer membrane control. Note 
that the PC fraction also contains intact cells, i.e., also contains OM proteins. 
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Figure 3.5. Protease accessibility of OspA:mRFP1 fusion mutants. Representative Western 
immunoblots of B. burgdorferi whole cell lysates expressing mutant OspA:mRFP1 fusions from 
an identical flaB promoter (Fig. 3.1) before (–) or after (+) in situ treatment with proteinase K 
(pK). A polyclonal antiserum against mRFP1 was used to detect the OspA:mRFP1 fusions. 
Constitutively expressed periplasmic FlaB was used as a control for loading (to normalize 
signals within samples) as well as for subsurface localization (negative control). OspA served as 
a surface control. Mutant-specific amino acid sequences are listed in single letter code above the 
blots. OspA28:mRFP1 and OspA20:mRFP1 (ED) were included as controls. 
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Figure 3.6. Distribution of OspA:mRFP1 fusion mutants to inner and outer membranes. 
 Representative Western immunoblots of protoplasmic cylinder (PC) and outer membrane 
vesicle (OM) fractions from B. burgdorferi expressing mutant OspA:mRFP1 fusions. A 
polyclonal antiserum against mRFP1 was used to detect the OspA:mRFP1 fusions. IM-localized 
lipoprotein OppAIV was used as a PC-specific control. Surface lipoprotein OspA was used as an 
outer membrane control. Note that the PC fraction also contains intact cells, i.e., also contains 
OM proteins. Mutant-specific amino acid sequences are listed in single letter code above the 
blots. OspA28:mRFP1 and OspA20:mRFP1 (ED) were included as controls. 
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Table 3.1.  Phenotypes of OspA20:mRFP1 fusion mutants 
 68 
 
 
 
 
 
 
 
 
 
Chapter IV  
Surface Localization Determinants of Borrelia OspC/Vsp Family Lipoproteins 
 
 
 
 
 
 
 
 
 
 
 
 69 
Abstract 
The dimeric OspC/Vsp family surface lipoproteins of Borrelia spirochetes are crucial to the 
transmission and persistence of Lyme borreliosis and tick-borne relapsing fever.  Yet, the 
requirements for their proper surface display remains undefined.  In previous studies, we showed 
that localization of Borrelia burgdorferi monomeric surface lipoprotein OspA was dependent on 
residues in the N-terminal ‘tether’ peptide.  Here, site-directed mutagenesis of the B. burgdorferi 
OspC tether revealed two distinct regions affecting either release from the inner membrane or 
translocation through the outer membrane.  Determinants of both of these steps appear 
consolidated within a single region of the Borrelia turicatae Vsp1 tether.  Periplasmic OspC 
mutants still were able to form dimers.  Their localization defect could be rescued by addition of 
an apparently fold-destabilizing C-terminal epitope tag, but not by co-expression with wild type 
OspC.  Furthermore, disruption of intermolecular Vsp1 salt bridges blocked dimerization, but not 
surface localization of the resulting Vsp1 monomers.  Together, these results suggest that 
oligomeric Borrelia surface lipoproteins traverse the periplasm and the outer membrane as 
unfolded monomeric intermediates and assemble into their functional multimeric folds only upon 
reaching the spirochetal surface. 
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Introduction 
Since the original description of a prokaryotic lipoprotein in the cell envelope of 
Escherichia coli over four decades ago (Braun and Rehn, 1969), this class of peripherally 
anchored membrane proteins has been increasingly appreciated.  In diderm bacteria, lipoproteins 
are routed via the general secretory pathway through and to the inner membrane (IM), where 
they are post-translationally modified by acylation at a conserved Cys residue (Hantke and 
Braun, 1973).  Sorting within the periplasm depends on variations of an N-terminal signal first 
identified in E. coli (Yamaguchi et al., 1988; Gennity and Inouye, 1991; Seydel et al., 1999; 
Lewenza et al., 2006; Narita and Tokuda, 2007; Silva-Herzog et al., 2008) and is carried out by 
the Lol system, consisting of the IM ABC transporter-like sortase complex LolCDE (Yakushi et 
al., 2000), the periplasmic lipoprotein carrier LolA (Matsuyama et al., 1995), and the outer 
membrane (OM) lipoprotein receptor LolB (Matsuyama et al., 1997; Yokota et al., 1999).  
Established pathways of lipoprotein translocation through the OM involve either a Type II or 
Type V secretion system (Pugsley et al., 1990; Pugsley, 1993; Francetic and Pugsley, 2005; 
Sauvonnet and Pugsley, 1996; Coutte et al., 2003; van Ulsen et al., 2003) 
Beyond the involvement of Braun’s lipoprotein Lpp in bacterial cell envelope stability 
(Braun and Wolff, 1970), lipoproteins were shown to play roles in a variety of cellular and 
pathogenic processes most recently reviewed by (Kovacs-Simon et al., 2010).  In Borrelia 
spirochetes, the etiologic agents of arthropod-borne Lyme disease and relapsing fever, surface 
lipoproteins are particularly abundant and constitute the predominant class of known virulence 
factors at the vector/host-pathogen interface (Brandt et al., 1990; Kudryashev et al., 2009; 
Bergström et al., 2010; Norris et al., 2010; Barbour and Travinsky, 2010).  Outer surface protein 
A (OspA), e.g., is expressed by the Lyme disease spirochete Borrelia burgdorferi during the 
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vector phase to facilitate adhesion to the tick midgut (Barbour et al., 1983; Pal et al., 2000; Pal et 
al., 2004).  Upon tick feeding and transmission to a new mammalian host, complex regulatory 
mechanisms lead to the replacement of OspA by OspC (Schwan et al., 1995; Stevenson et al., 
1995; Schwan and Piesman, 2000; Pal et al., 2001; Pal et al., 2004; Srivastava and de Silva, 
2008).  OspC is required for the establishment of mammalian infection (Grimm et al., 2004), via 
interaction with the Ixodes scapularis salivary gland protein, Salp15 (Anguita et al., 2002; 
Ramamoorthi et al., 2005).  OspC also binds plasminogen, which further enhances invasiveness 
(Lagal et al., 2006).  Variable small proteins (Vsp) are expressed by tick-borne relapsing fever 
spirochetes such as Borrelia turicatae and are phylogenetically and structurally related to OspC 
(Zückert et al., 2001; Lawson et al., 2006; Kumaran et al., 2001; Eicken et al., 2001).  They 
contribute to chronic infection of mammalian hosts by participating in an elaborate scheme of 
multiphasic antigenic variation designed to repeatedly evade the host’s immune response 
(Dworkin et al, 2008).  Vsps have also been shown to be the determinants of B. turicatae tissue 
tropism (Cadavid et al., 1994; Cadavid et al., 1997; Pennington et al., 1997; Pennington and 
Cadavid 1999; Gandhi et al., 2010) and may enhance invasion of tissues by binding to 
glycosaminoglycans (Magoun et al., 2000). 
Our previous investigations into the secretion of the major Borrelia surface lipoproteins 
led to some intriguing discoveries.  We first noticed that any known OM lipoprotein secretion 
modules, i.e., LolB, Type II or Type V systems, were missing from Borrelia genomes.  At the 
same time, relapsing fever Borrelia lipoproteins such as Vsp1 were compatible with the B. 
burgdorferi lipoprotein secretion machinery (Zückert et al., 2004).  This implied a novel genus-
wide mechanism for Borrelia OM lipoprotein targeting and translocation.  Using OspA as a first 
model lipoprotein, we subsequently showed that the established eubacterial sorting rules 
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(Yamaguchi et al., 1988; Gennity and Inouye, 1991; Seydel et al., 1999; Lewenza et al., 2006; 
Narita and Tokuda, 2007; Silva-Herzog et al., 2008) did not apply to borrelial lipoproteins 
(Schulze and Zückert, 2006).  Next, we discovered that a specific region in the OspA tether 
region is required for efficient OM translocation, and that C-terminal epitope tags of periplasmic 
OspA mutants were selectively displayed on the bacterial surface.  Additional OspA mutants 
indicated that the above described tether mutations lead to premature folding of OspA in the 
periplasm (Schulze et al., 2010).  This suggested that lipoprotein translocation through the outer 
spirochetal membrane requires an unfolded conformation of the substrate protein and can initiate 
at the C-terminus, yet is independent of a specific C-terminal targeting peptide. 
In this report, we expanded our studies to the OspC-Vsp family of proteins, which form 
dimeric α-helical bundles (Eicken et al., 2001; Kumaran et al., 2001; Lawson et al., 2006; 
Zückert et al., 2001) and therefore are structurally distinct from the OspA β-sheet monomer (Li 
et al., 1997; Becker et al., 2005).  The data now allow us to compare and contrast the secretion 
requirements of two different Borrelia surface lipoprotein folds.  Even more significantly, they 
permit us for the first time to establish the oligomeric state of lipoproteins throughout secretion. 
 
Results  
OspC-Vsp1 localization determinants are also confined to the tether, but minimal tether 
requirements differ from OspA. 
In two previous studies, we determined the N-terminal lipopeptides required for surface 
localization of monomeric OspA in fusions to the red-fluorescent reporter protein mRFP1.  
Using a standard protocol, which combined proteolytic ‘shaving’ to distinguish between surface 
and periplasmic lipoproteins along with the analysis of OM vesicle fractions to localize 
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periplasmic lipoproteins to either the IM or OM (see Chapter II), we originally concluded that 
five N-terminal residues of the mature OspA lipoprotein were sufficient for surface localization 
of mRFP1.  OspA20:mRFP1, providing only four OspA tether residues (Fig. 4.1A), was 
protected from proteolytic shaving with proteinase K, i.e., localized largely to the periplasm, 
while fusions of mRFP1 to OspA21 and longer lipopeptides were protease accessible, i.e., 
surface-displayed (Schulze and Zückert, 2006).  However, we later determined that four N-
terminal amino acids of mRFP1 contributed to the process and switched to a truncated mRFP1 
reporter, mRFPΔ4 (Schulze et al., 2010).  To enable direct comparison of OspA and OspC/Vsp1 
data, we revisited the OspA tether requirements and fused OspA20, OspA21, OspA22 and 
OspA25 (Fig. 4.1A) to mRFPΔ4.  As expected, the requirement shifted to longer OspA-derived 
lipopeptides: in contrast to the mRFP1 fusions, OspAV21 and OspAS22 tethers no longer were 
sufficient for surface exposure of mRFPΔ4; only OspA25:mRFPΔ4 remained surface exposed 
(Fig. 4.2A).  This indicated that nine N-terminal residues of mature OspA are sufficient for 
surface exposure. 
 As for OspA, fusions with OspC and Vsp1 full-length tether peptides were able to guide 
mRFPΔ4 properly through the spirochetal cell envelope and to the surface (Figs. 4.1, 4.2B and 
4.2C).  Yet, fusions to truncated OspC and Vsp1 tethers revealed some interesting differences.  
First, the minimal surface localization requirements were extended to tethers 12 and 14 amino 
acids in length, respectively. OspC30:mRFPΔ4 and Vsp1.32:mRFPΔ4 were displayed on the 
surface while OspC29:mRFPΔ4 and Vsp1.31:mRFP1Δ4 localized to the periplasm (Figs. 4.2B 
and 4.2C).  Longer and shorter tether fusion data were consistent with these surface-to-
subsurface transitions (data not shown).  In context with the previously published OspA-derived 
data (Schulze and Zückert, 2006; Schulze et al., 2010) these experiments corroborated a common 
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tether-dependent secretion pathway for Borrelia surface lipoproteins, which yet appears to 
tolerate significant primary sequence diversity. 
 
Tether mutagenesis reveals two separate OspC domains required for OM and surface 
targeting. 
Based on the fluorescent protein fusion data, we next deleted the N-terminal OspC and Vsp1 
peptide sequences deemed dispensable or essential for surface localization.  Tetherless OspCΔ20-41 
and Vsp1Δ20-39 mutants had a null phenotype i.e., no protein was detected.  Upon further 
examination, no mRNA was detected in cells expressing OspCΔ20-41 and Vsp1Δ20-39 as determined 
by northern blotting using DNA probes complementary to the ospC and vsp1 coding regions 
(Fig. 4.9).  The simplest explanation for this phenomenon is that site-directed mutagenesis 
resulted in the creation of a transcription termination sequence.   
As expected, deletion of the 'essential', anchor-proximal OspC tether peptide led to a 
defect, localizing OspCΔ20-30 to the periplasmic leaflet of the OM.  Surprisingly, the deletion of 
the 'dispensable' anchor-distal OspCΔ31-41 peptide also resulted in a sorting defect, largely 
retaining the construct in the IM.  Expansion of the tether by three residues in OspCΔ34-41 was 
required to restore surface localization. The smallest alterations leading to mislocalization of 
OspC were either single or double amino acid deletions in the +3 and +4 positions.  OspCΔN21, 
OspCΔS22 and OspCΔN21/S22 localized to the periplasmic leaflet of the OM.  Replacement of the two 
residues with either Gly or Ala dipeptides led to phenotypes already observed with OspA 
(Schulze et al., 2010): Ala-Ala in OspCN21A/S22A was permissive for surface exposure while Gly-
Gly in OspCN21G/S22G prevented proper translocation through the OM.  With the exception of a 
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triple +2/+3/+4 position residue deletion in OspCΔ20-22, deletions elsewhere within the tether did 
not affect OspC surface localization (Fig. 4.1 and Fig 4.3). 
Vsp1 tether deletion data tracked the mRFP1Δ4 fusion data (Fig. 4.4): Vsp1Δ33-39 
remained surface exposed while Vsp1Δ20-32 was retained in the periplasm.  A six-residue region 
(Asn20-Ser25) proximal to the N-terminal cysteine proved important for proper localization.  
Deletion of at least four of these six residues led to an OM translocation defect, localizing the 
respective mutants to the periplasmic leaflet of the OM.  Its full deletion in Vsp1Δ20-25 led to 
retention in the IM.  Yet, replacing the Pro residue in the +2 position with Ala in Vsp1Δ20-25/P26A 
restored release from the IM to the periplasmic leaflet of the OM.  Other deletions within the 
Vsp1 tether did not affect the surface phenotype (Fig. 4.4B).  Together, these experiments 
suggested that functional surface display of Borrelia lipoproteins required a subset of common 
tether amino acid residues, albeit with no stringent positional constraints relative to the N-
terminal cysteine. 
 
Tether peptides do not affect overall protein thermal stability. 
Several prior studies using maltose binding protein had shown that its signal peptide retarded 
protein folding to favor interactions with the SecB chaperone, thereby ensuring efficient 
secretion through the inner membrane Sec machinery (Park et al., 1988; Liu et al., 1989; Beena 
et al., 2004).  We therefore decided to test whether tethers of surface lipoproteins had similar 
intrinsic destabilizing capabilities.  Recombinant non-lipidated OspC variants were purified and 
their folded state was monitored over a temperature range from 25°C to 95°C by circular 
dichroism (CD) spectroscopy.  Three recombinant OspC (rOspC) variants were analyzed:  
rOspCN20 contained the full-length tether, replacing the N-terminal Cys with an fMet.  rOspCN31 
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and rOspCV37 lacked 11 or 17 N-terminal amino acids, respectively; a deletion identical to the 
one in rOspCN31 had resulted in the mislocalization of OspCD20-30 to the periplasm in vivo (Fig. 
4.3).  Circular dichroism spectra did not reveal any significant variations in the predominantly α-
helical secondary structure between the three proteins (Fig. 4.5A).  Thermal denaturation curves 
of all three proteins were virtually identical and had a single transition state at about 50°C (Fig. 
4.5B). This indicated that mutations within the tether, in the absence of other cellular proteins, 
resulted in only marginal changes in thermodynamic stability.    
 To verify these findings, we repeated the thermal unfolding experiments using an 
unrelated protein, OspA.  As mentioned before, OspA is monomeric and primarily composed of 
an open β-sheet.  Non-lipidated OspA with the full-length tether peptide (rOspAA17) and 
tetherless OspA (rOspAS29) were purified and thermal unfolding experiments performed as with 
OspC.  As with OspC, the CD spectra of OspA did not reveal any differences of the overall β-
sheet secondary structure (Fig. 4.5C).  However, rOspA is more thermal stable than rOspC, as 
there were only minor differences in secondary structure at 25°C compared to 80°C, which 
makes comparison of unfolding profiles between the two proteins difficult (data not shown).   
 
OspC mislocalized to the periplasm folds and dimerizes.   
We previously found that C-terminal fold-destabilizing mutations in OspA were able to 
overcome a tether-based mislocalization defect (Schulze et al., 2010) and interpreted this as a 
requirement for OspA to remain at least partially unfolded prior to translocation through the OM.  
Consequently, we surmised that premature folding leads to periplasmic retention of otherwise 
surface-displayed lipoproteins.  To further test this hypothesis, we determined the folding status 
of two periplasmic OspC mutants, OspCΔ20-30 and OspCΔ31-41.  A first approach built on earlier 
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observations that the tight α-helical bundles of wild type OspC and Vsp1 left only the proteins’ 
N– and C-termini vulnerable to trypsinolytic attack (Eicken et al., 2001; Kumaran et al., 2001; 
Lawson et al., 2006; Zückert et al., 2001).  The maintenance of trypsin-resistant OspC/Vsp ‘core’ 
proteins could therefore serve as a hallmark for a proper structural conformation.  To gain access 
to the periplasmic OspCΔ20-30 and OspCΔ31-41 proteins, we were required to permeabilize the 
borrelial envelope with 0.1% SDS (Jewett et al., 2007) prior to trypsin treatment.  In the presence 
of 0.1% SDS, OspCΔ20-30 and OspCΔ31-41 became trypsin-susceptible like OspCwt (Fig. 4.6A).  
Based on densitometry of Western immunoblot signals, we observed an approximately 2- to 3-
fold decrease in OspCΔ20-30 and OspCΔ31-41 compared to OspCwt.  The trypsin resistance of 
periplasmic OspC was comparable to that of surface OspA in the presence of detergent and 
significantly higher than that of periplasmic OM lipoprotein Lp6.6 (Fig. 4.6A).  In a second 
experiment, we probed the oligomeric state of periplasmic OspC by formaldehyde crosslinking 
and proteolytic shaving.  Upon addition of formaldehyde, we detected a 46-kDa band 
corresponding to the OspC dimer (Fig. 4.6B; (Bunikis and Barbour, 1999)).  The OspCΔ20-30 and 
OspCΔ31-41 dimers were protected from proteinase K, indicating their subsurface localization.  
Finally, a Far-Western protein overlay assay (Fig 4.6C) showed that OspCΔ20-30 and OspCΔ31-41 
were able to form functional epitopes that could interact with the Ixodes scapularis salivary 
gland protein Salp15 (Dai et al., 2009; Ramamoorthi et al., 2005).  Based on this evidence, we 
concluded that mislocalized OspC tether mutants were not blocked from assuming a proper 
conformation within the periplasm. 
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Fold destabilization of periplasmic OspC stimulates OM translocation.   
We previously found that C-terminal epitope tags of the periplasmic OspAΔS22 mutant were 
selectively surface exposed (Schulze et al., 2010).  To determine if an identically tagged OspC 
protein would have the same phenotype, we added a C-terminal His-tag to OspCΔ22.  To our 
surprise, not only the C-terminal tag, but the entire OspCΔS22-His became surface localized (Fig. 
4.7A).  Surface proteolysis with trypsin tested for the maintenance of the OspC trypsin-resistant 
core (Eicken et al., 2001; Kumaran et al., 2001; Zückert et al., 2001).  Cell-associated OspCwt, 
OspC-His and OspCΔS22-His proteins showed the expected proteolytic pattern, i.e., a removal of 
the C-terminus (Fig. 4.7B).  The trypsin-resistant core protein released from the cell into the 
reaction supernatant was clearly detectable for OspCwt, but not for the OspC-His and OspCΔS22-
His proteins.  This indicated that addition of a C-terminal epitope tag sufficiently destabilized the 
OspC fold to stimulate the mutant’s release from the periplasm to the spirochetal surface.  To 
exclude the possibility of an artifact introduced by the His tag these experiments were repeated 
using C-terminal FLAG tag with identical results (data not shown).  Together, these experiments 
further supported our earlier conclusions that trapping of surface lipoproteins within the 
periplasm is avoided by maintaining unfolded translocation intermediates. 
 
OspC and Vsp1 likely traverse the periplasm as monomeric intermediates.   
If unfolded periplasmic translocation intermediates were universal for surface lipoproteins, 
oligomerization interfaces of proteins such as the OspC/Vsp homodimers would likely be 
disrupted.  Therefore, these proteins would remain monomeric within the periplasm before 
assuming their final tertiary and quaternary structures on the spirochetal surface.  We used two 
approaches to test this hypothesis.  First, we asked whether periplasmic heterodimerization with 
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a wild type OspC monomer could 'rescue' a mutant subsurface OspC monomer to the bacterial 
surface.  We transformed B. burgdorferi strains B31-e2 and B313, which endogenously express 
wild-type OspC, with a plasmid that encodes for the periplasmic OspCΔ31-41 and OspCΔ20-30 
mutants, respectively.  Based on densitometry of Western blots, there was no shift in the protease 
accessibility of the mutant OspC proteins in the presence of wild type OspC and vice versa 
(Figure 4.6D).  This indicated that mutant and wild type OspC proteins failed to interact with 
each other in the periplasm.  
In a variation of this approach, we marked the periplasmic OspC∆20-30 with a HA-tag 
(YPYDVPDYA) and wild type surface OspC with a FLAG tag (DYKDDDDK) and attempted to 
co-immunoprecipitate the proteins with antibodies against their respective tags.  Cells expressing 
two surface-localizing FLAG or HA-tagged OspC copies served as control. No significant 
heterodimer levels were detected (Fig. 4.7C).  However, introduction of an HA tag into OspC 
generated a membrane localization artifact, as localization of OspCΔ20-30-HA is largely localized to 
the inner membrane, while OspCΔ20-30 is largely localized to the outer membrane (Fig 4.7B and 
4.3B).  Regardless of the localization artifacts introduced by the HA tag, the data clearly show no 
heterodimerization between a periplasmic OspC and a surface OspC (Fig 4.7). 
 Second, we set out to generate monomeric mutants of OspC and Vsp1 by disrupting 
intermolecular salt bridges by charge swapping.  All OspC mutants either still dimerized or had a 
null phenotype (Table 4.1).  However, an obtained triple Vsp1 D60K/D87K/D150K mutant (Fig. 
1B) was instructive.  Vsp1D60/87/150K was likely destabilized, as it was detected at a lower level 
than Vsp1wt.  In situ formaldehyde crosslinking and protease accessibility experiments showed 
that Vsp1D60K/D87K/D150K failed to dimerize, yet still reached the B. burgdorferi surface (Fig. 
4.6E).  This showed that dimerization was not required for Vsp1 surface localization.  Together, 
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these three experiments provided evidence for monomeric periplasmic intermediates of 
oligomeric surface lipoproteins. 
 
Vsp1 and Vsp2 form surface heterodimers when expressed in the same cell. 
Relapsing fever Borrelia express two different serotypes of Vsp lipoproteins during mammalian 
infection:  Vsp1 and Vsp2.  Both of these lipoproteins undergo antigenic variation during the 
course of infection and exhibit differential tissue tropism (Cadavid et al., 1997; Cadavid et al., 
1994; Pennington and Cadavid, 1999; Cadavid et al., 1993; Pennington et al., 1997).  We wished 
to determine if Vsp1 and Vsp2 could form heterodimers in vivo.  Heterodimerization between 
these two serotypes could function as an additional mechanism for antigenic variation.  To test 
this hypothesis, we introduced an HA tag into Vsp1 and a FLAG tag into Vsp2 (like with OspC 
above).  First, we expressed Vsp1-HA and Vsp2-FLAG in the same B. burgdorferi cell from 
separate plasmids.   We then performed co-immunopercipitation (Co-IP) using anti-HA and anti-
FLAG antibodies. Vsp1-HA and Vsp2-FLAG were immunoprecipitated irrespective of which 
antibody was used as bait (Fig 4.10).  As a control, we repeated the experiment using the Vsp1 
monomer mutant (Vsp1D60/87/150K-HA) and Vsp2-FLAG.  As expected Vsp1D60/87/150K-HA was 
immunoprecipitated only with anti-HA antibodies and Vsp2-FLAG was only 
immunoprecipitated with anti-FLAG antibodies (Fig 4.10).  Vsp1-HA, Vsp1D60/87/150K-HA, and 
Vsp2-FLAG and all were surface exposed (data not shown).  
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Discussion 
While major lipoproteins of diderm bacteria generally localize to the periplasmic leaflets of 
either the IM or OM depending on N-terminal sorting signals recognized by the Lol machinery, 
the sorting of major lipoproteins in Borrelia is inherently more complex due to the requirement 
of surface lipoproteins to cross the OM.  Our previous studies focused on the secretion 
requirements of the monomeric surface lipoprotein OspA (Schulze and Zückert, 2006; Schulze et 
al., 2010).  In the present study, we turned our attention to the Borrelia OspC/Vsp lipoproteins, a 
family of functionally diverse, but structurally conserved dimeric surface lipoproteins.  This 
represented an important next step toward our ultimate goal of defining canonical sorting rules 
for Borrelia lipoproteins.  It also provided first hints at how Borrelia cells cope with an 
additional layer of complexity during lipoprotein secretion: the oligomerization of dimeric 
lipoproteins. 
Although OspC and Vsp1 share the same protein fold, their overall peptide sequence 
identity is only about 40% (Eicken et al., 2001; Kumaran et al., 2001; Lawson et al., 2006; 
Zückert et al., 2001).  This heterogeneity extends into the membrane-distal tether portions and 
may explain most of the distinct secretion determinants for the two surface lipoproteins, e.g. the 
lack of a phenotype for the VspΔ33-39 mutant.  The first five tether residues, however, are 
conserved between OspC and Vsp1. It is therefore puzzling that the deletion of three residues 
internal to this pentapeptide yields a subsurface phenotype for OspCΔ20-22, but not for Vsp1Δ20-22.  
Deletion of the subsequent tripeptides does not affect surface localization of either OspCΔ23-25 or 
Vsp1Δ23-25.  This suggests that Vsp1 the Gly23/Thr24/Ser25 tripeptide is functionally redundant to 
Asn20/Asn21/Ser22.  Yet, we cannot exclude that some of the observed variances between OspC 
and Vsp1 are due to the heterologous expression of Vsp1 in the B. burgdorferi surrogate host.  
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While overall lipoprotein sorting mechanisms appear to be conserved within the genus Borrelia 
(Zückert et al., 2004), they might have undergone additional fine-tuning within individual 
species.  Unfortunately, the absence of a B. turicatae genetic system currently prevents further 
exploration of this issue. 
Several common attributes are emerging from a comparison of the now known Borrelia 
surface lipoprotein secretion requirements.  First, there is the confinement of lipoprotein 
targeting information to the N-terminal tether peptide.  This is not entirely surprising as the 
sorting rules previously identified in other diderm bacteria also implicate the N-termini of the 
mature lipoproteins (Yamaguchi et al., 1988; Silva-Herzog et al., 2008; Seydel et al., 1999; 
Narita and Tokuda, 2007; Lewenza et al., 2006; Gennity and Inouye, 1991).  Vsp1/OspC-derived 
peptides required for the proper secretion of the mRFPΔ4 reporter are at least 3 to 5 residues 
longer than the OspA minimal tether.  This may be a consequence of the above-mentioned 
optimization of different substrates for a common lipoprotein secretion machinery, and the 
significance of these length differences may be exaggerated due to the currently limited dataset.  
Second, the essential tether ‘motifs’ of OspA, OspC and Vsp1 (shaded in blue in Fig. 4.1A) 
commonly contain at least one Ser residue.  The significance of this apparent conservation 
remains to be elucidated.  Also conserved is the tolerance for Ala, but not Gly substitutions 
within these ‘motifs’ of OspA and OspC (Fig. 4.3;(Schulze et al., 2010)).  This further supports 
our earlier conclusions that a defined degree of flexibility within a critical tether segment is 
required for proper function.   
It is worth reiterating that the above described essential tether ‘motifs’ are otherwise quite 
variable in sequence, extent and spacing relative to the N-terminal acylated cysteine ‘+1’ residue.  
This further bolsters our OspA-based conclusions regarding the absence of a positional 
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‘+2/+3/+4’ rule for Borrelia lipoproteins.  On first sight, the Vsp1Δ20-25 and Vsp1Δ20-25/P26A 
mutants may provide a counter-argument, as they conclusively show that a Pro residue at 
position ‘+2’ specifically leads to lipoprotein mislocalization to the B. burgdorferi IM.  Yet, 
secondary structure-disrupting prolines are found throughout the tethers of B. burgdorferi 
lipoproteins, except in the ‘+2’ position (Setubal et al., 2006; Schulze et al., 2006).  Therefore, a 
‘+2’ Pro should be considered a non-native lipoprotein IM retention signal, which interestingly is 
shared across genus barriers with E. coli (Schulze et al., 2010; Setubal et al., 2006).  As such, it 
might be of questionable biological relevance, but may hint at common molecular mechanisms.  
In the context of our earlier identification of borrelial LolCDE and LolA homologs, as well as 
basic amino acids serving as borrelial IM retention signals (Schulze et al., 2010; Zückert et al., 
2004; Kumru et al., 2010), we therefore propose that the lipoprotein sorting mechanisms in the 
IM of diderm bacteria are conserved on a general level, albeit with variations in the exact nature 
and placement of the IM retention or Lol avoidance signals. 
The current OspC/Vsp1 data also corroborate the previously established OspA-derived 
requirements for lipoprotein translocation through the OM.  First, the ability of a Vsp1 monomer 
and a fold-destabilized, otherwise periplasmic OspC mutant to reach the bacterial surface further 
supports the requirement of the OM lipoprotein translocation machinery for at least partially 
unfolded substrates (Schulze et al., 2010).  The apparent differences in the phenotypes of C-
terminally tagged, otherwise periplasmic OspA and OspC mutants may be explained by the 
structural differences between the two proteins.  In OspA, C-terminal tags are distal from the N-
terminal membrane tether and likely will act as separate protein domains.  In OspC, however, the 
proximity of both protein termini may cause the C-terminal tags to sterically interfere with the 
formation of a tight α-helical bundle.  Second, OspC and Vsp1 tether mutants mislocalizing to 
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the periplasm were not prevented from folding and assembling into quaternary structures.  Yet, 
wild type OspC molecules failed to rescue mutant mislocalized OspC molecules to the 
spirochetal surface.  This might be due to sequestration of the wild type protein from the mutant 
isotype.  In light of the other data, however, it is best explained by the failure of wild type 
lipoprotein dimer subunits to form proper intermolecular interfaces in the periplasm.  Third, the 
in vitro studies of recombinant OspC proteins with various tether deletions demonstrated that the 
tether peptide did not significantly affect the thermal stability of the OspC fold.  This suggests 
that tether peptides of surface lipoproteins such as OspC do not possess intrinsic fold-
destabilizing properties, i.e., most likely require binding to a ‘holding’ chaperone to prevent 
premature folding in the periplasm and thereby exclusion from the bacterial surface. 
Future studies will continue to define sorting determinants for other mono- and 
multimeric lipoproteins targeted to different subcellular compartments, test the involvement of 
the Lol machinery in the secretion of surface lipoproteins, and aim to identify additional 
lipoprotein secretion pathway components, including the proposed OM lipoprotein flippase 
complex.  Together, these studies will continually refine our working model of how B. 
burgdorferi targets its most important class of virulence factors to the host-pathogen interface. 
 
 
 
 
 
 
 
 85 
Table 4.1. Phenotypes of OspC-Vsp1 salt bridge charge swap point mutations 
 
Protein Point Mutations    Phenotype 
OspC     
E61K      Dimer 
  E61K/E90K/H93K    Null   
  E61K/E90K/H93K/E148K   Null 
  E61K/K111A     Dimer 
  E61K/E90K/H93K/E148K/K111A  Null 
  E90K/H93K/E148K    Dimer 
Vsp1     
D60K      Dimer 
  D60K/D87K     Dimer 
  D60K/D87K/D150K    Monomer 
  D60K/D87K/D150K/E191K   Null 
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Fig. 4.1.  Genotypes and phenotypes of OspC and Vsp1 mutants.   
(A) N-terminal sequences of mature lipoproteins OspA, OspC and Vsp1 are shown in single 
letter amino acid code.  The ‘+1’ position Cys residue is marked with an arrowhead.  Numbers 
above the residues indicate their position in the pro-lipoprotein including the cleaved signal 
peptide.  Greek letters above boxed residues indicate secondary structure elements as determined 
by X-Ray crystallography (Eicken et al., 2001; Kumaran et al., 2001; Lawson et al., 2006; Li et 
al., 1997).  Red lines with boxed ends underline the minimum tether sequences required for 
surface localization of mRFPΔ4.  Lines flanked by inverted arrowheads span the peptides deleted 
in the respective tether mutants.  Black lines/bold letters mark mutants with non-wild type 
phenotypes.  Gray lines/regular letters mark mutants with a wild type phenotype.  Boxed shaded 
in light blue indicate the essential tether ‘motifs’ of OspA, OspC and Vsp1.  (B) A ribbon 
representation of the Vsp1 tertiary structure (PDB ID 2GA0;(Lawson et al., 2006)) was 
generated using the CCP4 software for Macintosh (version 2.4.3; (Potterton et al., 2002)).  The 
two Vsp1 chains are colored light blue and pink, respectively.  Residues involved in salt bridging 
of the monomers are highlighted as red (Asp) or blue (Lys) spheres representing the Cα and side 
chain atoms.  The bolded residues were mutated to yield the Vsp1 monomer.  Val38 and Leu201 
are the first and last residues visible in the crystal structure. 
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Fig. 4.2.  Minimal OspA, OspC and Vsp1 tether sequence requirements for surface display 
of the mRFPΔ4 reporter.  Proteinase K (pK) accessibility immunoblots of OspA (A), OspC (B) 
and Vsp1 (C) tether fusions to mRFPΔ4 compared with OspCwt.  FlaB is used as a periplasmic, 
protease-resistant control.  OspA and OspC are used as surface, protease sensitive controls.   
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Fig. 4.3.  Localization of OspC mutants. 
(A) Proteinase K (pK) accessibility immunoblots of OspC tether mutants compared with OspAwt.  
FlaB was used as a periplasmic, protease-resistant control.  (B) Membrane fractionation 
immunoblots of proteinase K-resistant, i.e., periplasmic OspC tether mutants compared with 
OspAwt. OppAIV served as IM control. OMV, outer membrane vesicle fraction; PC, 
protoplasmic cylinder fraction (also containing intact cells; (Schulze and Zückert, 2006; Skare et 
al., 1995)).  The OMV ratio was calculated from densitometry data that were normalized to both 
OspA and OppAIV as described (Kumru et al., 2010).  An asterisk (*) in both panels indicates an 
OspC degradation product dependent on the periplasmic CtpA protease (Östberg et al., 2004, 
Chapter V); cleavage of OspC by CtpA is stimulated by periplasmic retention of the substrate or 
by addition of a C-terminal epitope tag (see also Figs. 4.4, 4.6 and 4.7; Chapter V). 
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Fig. 4.4.  Localization of Vsp1 mutants.   
(A) Proteinase K (pK) accessibility immunoblots of Vsp1 tether mutants compared with OspCwt.  
FlaB was used as a periplasmic, protease-resistant control.  (B) Membrane fractionation 
immunoblots of proteinase K-resistant, i.e., periplasmic Vsp1 tether mutants compared with 
OspCwt.  OppAIV served as IM control. OMV, outer membrane vesicle fraction; PC, 
protoplasmic cylinder fraction (also containing intact cells; (Schulze and Zückert, 2006; Skare et 
al., 1995).  An asterisk (*) in both panels indicates a Vsp1 degradation product dependent on the 
periplasmic CtpA protease (Chapter V; (Östberg et al., 2004)) 
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Fig. 4.5.  Circular dichroism and thermal denaturation data for recombinant OspC and 
OspA tether deletion mutants.  Circular dichroism spectra of recombinant (A) OspC and (C) 
OspA proteins.  Per-residue ellipticity [Θ] plotted as a function of wavelength indicates that all 
mutants have similar structure dominated by an (A) α-helical or (C) β-sheet conformation.  All 
spectra were obtained at 25º C in 10mM NaPO4 buffer.  Thermal unfolding of rOspC proteins 
determined as change in ellipticity at 222 nm with solid lines represented fitting to a two-state 
transition model.  (B) The values for the transition enthalpy ΔH and the free energy of the native 
state ΔG (both in kcal/mol) are shown in the insert, along with the transition temperature.  
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Figure 4.6.  Structural and functional analysis of select OspC and Vsp1 mutants.  (A) 
Trypsin (tryp) resistance immunoblots of periplasmic OspC tether mutants compared to OspCwt, 
Surface OspAwt and periplasmic lipoprotein Lp6.6 were used as OM lipoprotein controls.  FlaB 
was used as a loading control.  0.1% SDS was used gain access of trypsin to the periplasm.  Note 
that OspA becomes more susceptible to trypsin in the presence of detergent.  (B) Dimerization 
and proteinase K (pK) accessibility immunoblots of periplasmic OspC tether mutant compared to 
OspCwt.  Formaldehyde (form) crosslinking was used to stabilize OspC dimers (Bunikis and 
Barbour, 1999).    FlaB was used as both periplasmic, protease-resistant and loading control.  (C) 
Far-Western overlay blot of periplasmic OspC tether mutants with recombinant Salp15 tick 
salivary gland protein.  Whole cell lysates of an OspCwt-expressing B. burgdorferi strain 
obtained before and after proteolytic shaving with proteinase K (pK) were used as control.  (D) 
Proteinase K (pK) accessibility immunoblots of OspC tether mutants ectopically expressed in an 
OspCwt-deficient (B31-A3 ospC::kan; ΔospCwt) or OspCwt-expressing (B313; ospCwt+) 
backgrounds (bg).  Note that there is no reduction in the mutant OspC protein band marked by a 
pound sign (#) upon protease treatment, independent of background.  FlaB served as a 
periplasmic, protease-resistant and loading control. (E) Dimerization and proteinase K (pK) 
accessibility immunoblots of the Vsp1 triple salt bridge mutant compared to Vsp1wt.  
Formaldehyde (form) crosslinking was used to stabilize any existing Vsp1 dimers (Bunikis and 
Barbour, 1999).  FlaB was used as both periplasmic, protease-resistant and loading control.  Note 
that the mutant Vsp1 samples had to be overloaded to sufficiently visualize the Vsp1 monomer.  
An asterisk (*) in panels A, B and D indicates an OspC degradation product dependent on the 
periplasmic B. burgdorferi CtpA protease (Chapter V (Östberg et al., 2004)) 
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Figure 4.7.  Additional evidence OspC transverses the OM as a monomeric intermediate. 
(A) Proteinase K (pK) accessibility immunoblots of B31-A3 ospC::kanR cells that express 
OspCΔ20-30-HA and OspC-FLAG indicate OspC-HA and OspC-FLAG, but not OspCΔ20-30-HA are 
surface exposed.  FlaB was used as a periplasmic, protease-resistant control and OspA was used 
as a protease sensitive control.  (B) Membrane fractionation immunoblots of proteinase K-
resistant, i.e., periplasmic OspCΔ20-30-HA compared with OspAwt. OppAIV served as IM control. 
OMV, outer membrane vesicle fraction; PC, protoplasmic cylinder fraction (also containing 
intact cells; (Schulze and Zückert, 2006; Skare et al., 1995)).  Note the artifact introduced by the 
HA tag (see Fig 4.3 for OspCΔ20-30)  (C) Co-immunoprecipitation indicates heterodimerization of 
OspC occurs only when OspC-FLAG and OspC-HA are localized to the same cellular 
compartment.  All immunoprecipitation were repeated using anti-mouse IgG as a negative 
control.   
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Figure 4.8.  Structural analysis of epitope-tagged OspC mutants.  (A) Proteinase K (pK) 
accessibility immunoblots of C-terminally histidine-tagged OspC tether mutant OspCΔS22 
compared with to a histidine-tagged OspCwt.  OspA was used as a surface control, and FlaB was 
used as a periplasmic, protease-resistant and loading control.  A HisProbe-HRP (Ni2+-HRP) 
conjugate was used to confirm the full-length protein band.  (B) Trypsin (tryp) resistance 
immunoblots of C-terminally histidine-tagged OspC tether mutant OspCΔS22 compared with to a 
histidine-tagged OspCwt and untagged OspCwt.  FlaB was used as a loading control.  Arrowheads 
mark the bands corresponding to full-length proteins (full) and trypsin-resistant core proteins 
(trunc) released from the cell into the reaction supernatant (Zückert et al., 2001).  An asterisk (*) 
in both panels indicates an OspC degradation product dependent on the periplasmic CtpA 
protease (Chapter V (Östberg et al., 2004)). 
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Figure 4.9.  Phenotypes of tetherless OspC and Vsp1 mutants.   
(A) Western immunoblots using monoclonal and polyclonal OspC antibodies indicate no OspC 
is synthesized.  Northern blots using DNA probes complementary to (B) ospC and (C) vsp1 
coding regions indicate no ospC or vsp1 mRNA is present.  Total RNA from cells harboring wild 
type plasmids and empty vectors were used as positive and negative controls, respectively.  RNA 
gels stained with EtBr are shown as a loading control.   
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Figure 4.10. Heterodimerization of Vsp1 and Vsp2. 
(A) Co-immunoprecipitation of Vsp1-HA/Vsp2-FLAG expressing cells and Vsp1D60K/D87K/D150K-
HA/Vsp2-FLAG expressing cells using anti-HA and anti-FLAG tag antibodies.  Introduction of 
Vsp1 salt bridge mutations in Vsp1-HA abrogates heterodimerization with Vsp2.  Co-
immunoprecipitations were repeated using anti-c-Myc antibodies as a negative control.  (B) An 
independent experiment as in (A) but, probing the immunopercipitate for HA, FLAG, Vsp1, 
Vsp2, OspC, and FlaB antibodies.  Protein A alone was used as a negative control.  For details of 
the different antibodies used see Table 2.2.   
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Chapter V. 
Evidence for an Expanded Role of Borrelia burgdorferi CtpA Protease in 
Envelope Biogenesis 
 
 
 
 
 
 
 
 
 
 
 99 
Abstract 
Proteolytic processing of secreted proteins commonly occurs at the N-terminus, where signal 
peptides are removed after Sec-dependent translocation through the cytoplasmic membrane.  C-
terminal proteolytic processing, e.g., by the Sortase system in gram-positive bacteria also occurs, 
but overall is poorly understood.  Recently, an unusual serine-like periplasmic protease, CtpA, 
was discovered in Borrelia burgdorferi, the spirochetal agent of Lyme disease.  Inactivation of 
ctpA in B. burgdorferi did not affect growth in vitro, but had a pleiotropic processing defect.  
Known substrates of CtpA include the 13-kDa outer membrane porin P13 and a periplasmic 
lipoprotein that contains a LysM domain, which presumably functions to bind peptidoglycan to 
maintain integrity of the envelope.  While investigating lipoprotein sorting rules and analyzing 
several mutants of B. burgdorferi outer surface lipoprotein C (OspC), we discovered a lower 
molecular weight variant of OspC.  Ectopic expression of OspC with a C-terminal histidine tag 
in a ctpA knockout strain showed that CtpA is responsible for C-terminal cleavage of OspC.  C-
terminal processing in ctpA+ and ctpA- strains was about 50% and <1%, respectively.  
Interestingly, a higher molecular weight variant of OspC was detected in the ctpA- strain that 
could be a result of incomplete removal of the signal peptide at the N-terminus.  Taken together, 
these results suggest that CtpA can also function as a periplasmic housekeeping protease. 
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Introduction 
Proteolytic processing performs essential physiological functions in all bacteria.  N-terminal 
proteolysis of Sec substrates via signal peptidases is the most common and well characterized 
example (Manting and Driessen, 2000).  Overall C-terminal processing is rare in gram-negative 
bacteria and limited information is available concerning this phenomenon.  However, C-terminal 
processing commonly occurs in gram-positive bacteria via the Sortase system.  The sortase 
system functions to attach proteins to the cell surface after cleavage of the C-terminal sorting 
signal (LPXTG).  The Sortase substrate is then anchored to the peptidoglycan layer via 
transpeptidation (Cossart, 2000). 
As part of our analysis of the requirements for proper surface display of OspC, we 
introduced mutations within the N-terminal OspC tether peptide that led to mislocalization of the 
lipoprotein to the periplasm.  A common trait of the periplasmic OspC (and Vsp1) mutants was 
the presence of an additional protein band (labeled OspC*) that reacted with an OspC mouse 
monoclonal antibody (MAb) (Mbow et al., 1999), but at about 19-kDa had a lower apparent 
molecular mass than the 21-kDa wild type OspC (Chapter IV, Figs 4.3, 4.4).  Expression of a C-
terminally hexahistidine-tagged OspC (OspC-His) also yielded an OspC* band, which lacked 
reactivity with a HisProbe Ni2+-horse radish peroxidase conjugate (Chapter IV, Fig 4.8).  We 
therefore concluded that OspC* resulted from C-terminal cleavage (see Chapter IV, Fig 4.3). 
 An obvious candidate for mediating this process was CtpA, a recently identified B. 
burgdorferi serine-like C-terminal protease involved in processing of both outer membrane 
porins such as P13 or periplasmic lipoproteins such as BB0323 (Stewart et al., 2004; Noppa et 
al., 2001; Östberg et al., 2004).  Homologues of CtpA are mostly found in cyanobacteria, but are 
also found in pathogenic bacteria (Mitchell and Minnick, 1997; Ivleva et al., 2000; Bandara et 
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al., 2005; Bandara et al., 2008; Hoge et al., 2010). 2D gel analysis revealed potential substrates 
for CtpA, although the identity of some of these substrates remains unclear (Östberg et al., 
2004).  We therefore decided to investigate CtpA’s potential role in OspC processing. 
 
Results 
C-terminal processing of OspC is stimulated by addition of a C-terminal linker. 
We first set out to further define the substrate requirements for OspC C-terminal processing and 
modified the recombinant OspC expression plasmid pOSK200 (Table 2.3) by oligonucleotide-
mediated site directed mutagenesis yielding recombinant plasmids pOSK360 and pOSK277.  
pOSK360 encoded for OspC-link, an OspC tagged with a C-terminal PGGSGA linker peptide 
also present in OspC-His (Fig. 5.1).  pOSK277 encoded for OspC-L2his, an OspC with a His tag 
inserted between residues Lys116 and Asn117 in loop 2 (Table 2.3, Fig.5.1, ref. (Kumaran et al., 
2001).  Using established protocols (Samuels, 1995; Stewart et al., 2001), we transformed B31-
A3 (ΔospC), an OspCwt-deficient background strain (Table 2.1) with both pOSK360 and 
pOS307. The results showed that addition of the 6-amino-acid linker peptide alone in OspC-link 
was sufficient to stimulate cleavage and resulted in the OspC* band. Conversely, OspC-L2His 
did not yield an OspC* band i.e., was not a substrate for processing (Fig. 5.1 and Fig 5.2A).  This 
showed that C-terminal processing of OspC was specifically stimulated by the addition of 
unordered peptides to the lipoprotein’s C-terminus. The intensity of the OspC and OspC* bands 
were consistently similar.  Therefore, we reasoned processing efficiency was about 50%.  As 
additional controls, we also fused a FLAG tag and full-length mRFP1 to the C-terminus and 
introduced them into B31-A3 (ΔospC).  As expected, both the FLAG tag and mRFP1 were 
cleaved from the C-terminus at an efficiency of about 50% (data not shown).  
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CtpA is responsible for C-terminal proteolysis of OspC. 
To probe CtpA’s involvement in processing of OspC, we transformed the ctpA knockout mutant 
B31-A (ΔctpA), its complemented derivative B31-A(ΔctpA)/pBSV2G+ctpA (ref. (Östberg et al., 
2004) ; gifts from S. Bergström), as well as its parent strain B31-A (ref.(Bono et al., 2000); a gift 
from P.A. Rosa) with pOSK307 encoding OspC-His (Fig. 5.1, Table 2.3). In Western 
immunoblot assays, the OspC* band was not detectable in the ctpA knockout strain, but present 
in the CtpA-expressing B31-A background as well as the complemented ctpA deletion strain 
(Fig. 5.2B), which confirmed CtpA’s involvement in this process.  
We wished to confirm OspC with an unmodified C-terminus was a suitable substrate for 
CtpA.  When we overloaded immunoblots of cells expressing wild type OspC we detected 
OspC*, albeit at significantly lower levels (Fig. 5.2A).  Since expression of wild type OspC is 
low in B31-A (ΔctpA), we transformed this strain with a plasmid that expresses OspC from the 
constitutive flaB promoter (pOSK200, Table 2.3), which greatly increased OspC expression.  As 
expected, OspC* was not detected in the ctpA knockout strain that expressed wtOspC (Fig. 
5.2C).  This confirmed wild type surface OspC is a CtpA substrate, albeit at a relatively low 
incidence. 
 
CtpA-dependent proteolysis of OspC occurs at or around Ala204. 
To map the extent of the C-terminal OspC peptide removed by CtpA, we truncated OspC beyond 
the C-terminal α-helix (Kumaran et al., 2001) by replacing Ala204 with a stop codon by site 
directed mutagenesis of pOSK200 as described above (Tables 2.3, Fig. 5.1).  The OspCA204X and 
OspC* proteins co-migrated on SDS-PAGE, as detected by Western immunoblotting with the 
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OspC MAb (Fig. 2A).  Thus we concluded that CtpA removed OspC’s disordered C-terminal 
residues, cleaving at or close to Ala204.  Such a proteolytic site would be similar, if not identical 
to the site identified in P13, where CtpA cleaves after an Ala residue (Noppa et al., 2001).  We 
also observed a minor band derived from wild type OspC that co-migrated with OspC*, 
suggesting CtpA dependent proteolysis of wild type OspC occurs at the same residue as OspC-
His and OspC-link (Fig. 2A). 
 
CtpA inactivation results in detection of a higher molecular weight species of OspC. 
In addition to the OspC* and full-length OspC-His protein bands, three higher molecular weight 
variants with molecular masses around 26 kDa (labeled OspC‡) were prominent in immunoblots 
of the ctpA knockout strain with the anti-OspC MAb (Fig. 5.2B).  Only the largest OspC‡ band 
reacted with an anti-His MAb (HIS-1, Sigma), suggesting that the variants originated from both 
OspCwt and OspC-His expressed by the B31-A derivatives (Fig. 5.2B).  Triton X-114 
partitioning and proteolytic shaving assays indicated that both OspC* and OspC‡ protein species 
were associated with the membrane (Fig. 5.3A) and were surface exposed (Fig. 5.3B).   
 
Discussion 
This study shows that B. burgdorferi CtpA is responsible for the lower molecular weight variants 
observed when OspC is modified with a C-terminal epitope tag or mislocalized to the periplasm.  
Interestingly, OspC-His expressed in a ctpA knockout strain resulted in a higher molecular 
weight variant of OspC at about 26 kDa.  Östberg and colleagues had previously observed higher 
molecular mass variants of P13 in the ctpA knockout and speculated that they may result from 
the incomplete removal of its N-terminal type I signal peptide by signal peptidase I (Östberg et 
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al., 2004).  Analogously, treatment of Borrelia cells with the signal peptidase II inhibitor 
globomycin was shown to yield higher molecular mass lipoprotein species (Carter et al., 1994).  
Therefore, incomplete N-terminal OspC processing may best explain the OspC‡ variants.  Yet, it 
remains perplexing that such a defect would not impact the variants’ surface localization.  It is 
conceivable that (i) the partial acylation of the N-terminal cysteine, which generally occurs 
before signal peptide cleavage (Fig 1.1 and 1.6), is sufficient for membrane anchoring, and that 
(ii) the accumulating non-mature lipoproteins eventually overwhelm secretion substrate 
checkpoints and ultimately reach the bacterial surface via the standard borrelial lipoprotein 
transport pathway.  Steady-state analyses as the ones performed here would be unlikely to detect 
the expected differences in secretion efficiencies. 
Our observation of CtpA-mediated cleavage of the surface lipoprotein OspC raises some 
intriguing questions regarding the protease’s functional range.  Processing of wild type OspC 
was detectable, but was significantly stimulated by disordered C-terminal extensions described 
here or by mislocalization of OspC and the related B. turicatae Vsp1 to the periplasm described 
in Chapter IV.  CtpA may therefore act as a promiscuous housekeeping protease that removes 
structurally unconstrained C-termini of proteins in the periplasm.  In that case, OspC may be a 
mere target of opportunity that becomes particularly attractive if its escape from the periplasm is 
hindered.  However, the observed low-frequency C-terminal cleavage of wild type OspC may 
also represent evidence for a quality control mechanism that senses proper translocation of 
surface lipoproteins by detecting the release of C-terminal peptides.  Disruption of such a 
mechanism may elicit a bacterial envelope stress response, which in part could be responsible for 
the secondary effects of ctpA deletion observed by Östberg et al. (Östberg et al., 2004).   
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We previously did not notice any C-terminal processing of B. burgdorferi OspA 
periplasmic mutants (Schulze and Zückert, 2006; Schulze et al., 2010).  This simply might be 
due to the confinement of OspA’s C-terminus in α-helical secondary structure (Li et al., 1997) or 
point to a more limited checkpoint role for CtpA.  The role CtpA plays in the infectious process 
is still unknown.  Interestingly, inactivation of ctpA in Burkholderia mallei and Brucella suis 
significantly attenuates the bacteria in macrophages and mice, respectively (Bandara et al., 2005; 
Bandara et al., 2008).  Given the number of potential substrates observed via 2D gel analysis 
(Östberg et al., 2004) and the identification of OspC as a substrate, full or partial attenuation of 
B. burgdorferi in the mouse model by inactivation of ctpA remains a possibility.  If CtpA plays a 
role in activation of an envelope stress response, then gene inactivation of ctpA could lead to OM 
permeabilization and/or other envelope defects during the course of mammalian infection.  Thus, 
making clearance by the immune system a far simpler task.  Based on these findings, we 
advocate additional studies defining the proteolytic specificities and precise biological role(s) of 
CtpA in envelope biogenesis and host-pathogen interactions of this globally important 
spirochetal pathogen. 
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Figure 5.1. Partial peptide sequences of wild type and mutant OspC proteins.   
The residues confined to the α-helices of OspC are boxed and numbered.  Residue numbers of 
the signal peptide-containing pro-OspC lipoprotein are shown above the sequences.  Labeled 
brackets mark the linker and epitope tag sequences.  A gray box indicates the predicted CtpA 
cleavage site; Note that the C-terminus of P13 is cleaved after an Ala residue (ref. (Noppa et al., 
2001) also see text).   
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Figure 5.2. CtpA-dependent proteolytic processing of OspC.   
Western immunoblots of whole cell protein preparations obtained from cells expressing wild 
type (wt) or mutant OspC proteins in CtpA-expressing or (–) deficient strain backgrounds.  
Positions of molecular mass markers (in kilodaltons) are indicated to the left of each panel.  A 
bracket denotes the three higher molecular weight OspC‡ bands; arrowheads point to the OspCwt 
or OspC-His protein bands; an asterisks marks the OspC* band. (A) OspCwt and all OspC 
mutants are expressed in the B31-A3 (ΔospC) background (Table 2.2).  Left panel: The right-
most lane contains an overloaded OspCwt sample to visualize the OspCwt-derived OspC* band.  
FlaB was used as a loading control.  Right panel: The HisProbe Ni2+-HRP conjugate (Pierce) was 
used to confirm the mobility of the OspC-His band.  (B) Strain backgrounds are indicated by 
ctpA phenotype below the panel as follows: +, B31-A; Δ, B31-A (ΔctpA); Δ/C, B31-A 
(ΔctpA)/pBSV2G+ctpA (Table 2.2).  Left panel: CtpA was detected by a polyclonal rabbit 
antibody (Östberg et al., 2004).  FlaB served as a loading control.  Right panel: Whole cell 
protein preparations separated SDS-PAGE in adjacent lanes, blotted and probed with His and 
OspC antibodies.  Note that anti-His only reacts with the uppermost OspC‡ band.  Other labels 
are identical to Fig. 5.2A.  (C) OspC* is detected in ctpA+ strains expressing wtOspC.  OspC* is 
dependent on CtpA and independent of C-terminal modification.   
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Figure 5.3. Localization of CtpA-dependent OspC variants.   
Western immunoblots of protein preparations obtained from cells expressing wild type (wt) or 
OspC-His proteins in CtpA-expressing or deficient strain backgrounds.  Positions of molecular 
mass markers (in kilodaltons) are indicated to the left of each panel.  A bracket denotes the three 
higher molecular weight OspC‡ bands; arrowheads point to the OspCwt or OspC-His protein 
bands; an asterisks marks the OspC* band.  Strain backgrounds are indicated by ctpA phenotype 
below the panel as follows: +, B31-A3 (ΔospC); Δ, B31-A (ΔctpA). (A) Triton X-114 detergent 
(DT) and aqueous (AQ) protein fractions were probed.  OspA and FlaB were used as membrane-
associated and soluble controls, respectively.  (B) Protease-accessibility assay of the OspC-His 
derived variant protein bands produced in a CtpA-deficient background.  – pK, untreated cells; + 
pK, cells treated with 200 µg ml-1 proteinase K.  OspA and FlaB were used as surface and 
subsurface controls, respectively. 
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Chapter VI. 
Cross genus expression and localization of lipoproteins 
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Abstract 
 Bacterial lipoproteins are a distinct class of peripheral membrane proteins that serve a 
diverse number of functions.  In E. coli lipoproteins usually function to maintain integrity of the 
cell envelope as the majority of lipoproteins are localized to the periplasmic face of the outer 
membrane.  However, lipoproteins in the Lyme disease spirochete, Borrelia burgdorferi, are 
mostly localized to the bacterial surface and function as virulence factors.  Lipoproteins are 
sorted through the LolCDE machinery, a dedicated lipoprotein ABC transporter.  In E. coli, 
interaction with LolCDE is dependent on the residue immediately downstream of the tri-acyl 
modified cysteine and is known as the +2 rule.  B. burgdorferi lipoproteins do not adhere to the 
+2 rule or any other established lipoprotein sorting rules.   Recently, the question was posed if 
Borrelia lipoproteins could be correctly localized within the envelope independent of the 
Borrelia cell envelope.  In this study we expressed B. burgdorferi OspA fused to mRFP1 in E. 
coli and expressed Braun’s lipoprotein (Lpp) in B. burgdorferi.  Localization of OspA:mRFP1 in 
E. coli was dependent on the +2 rule while Lpp expressed in B. burgdorferi was localized to the 
inner membrane.  These results indicate that expression of a lipoprotein alone is not a sufficient 
mediator for proper localization.  Furthermore, lipoproteins ectopically expressed in a non-native 
surrogate hosts adhere to the lipoprotein sorting rules of the host.  Finally, this data argues 
against spontaneous membrane insertion as a mechanism for translocation of bacterial 
lipoproteins. 
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Introduction 
Lipoprotein sorting rules have been well established in E. coli and other Enterobacteriaceae.  
Yet, we are only beginning to elucidate the mechanisms that govern lipoprotein sorting in 
Borrelia burgdorferi.  Although, B. burgdorferi contains homologues to several proteins that 
make up the Lol machinery (LolACDE), it lacks an obvious LolB homologue that functions to 
insert lipoproteins in the outer membrane in other eubacteria.   
 The question was posed if expression of lipoproteins alone is sufficient to facilitate 
proper localization to their respective subcellular compartments.  Perhaps B. burgdorferi 
lipoproteins are self-contained translocation machines that can spontaneously insert into and 
across the outer membrane?  This possibility is unlikely due to the lack of a C-terminal 
translocator domain (β domain), like those found in autotransporters (Type V secretion system).  
Regardless, little experimental data is available to disprove this hypothesis.  Localization of B. 
burgdorferi OspA in E. coli reveals that it is not surface exposed, but rather associated with the 
inner membrane (Dunn et al., 1990).  To further answer these questions we used previously 
localized fusions of B. burgdorferi Outer Surface Protein A (OspA) to monomeric red 
fluorescent protein 1 (mRFP1).  We used fusions that localized to the inner membrane and 
surface in B. burgdorferi and expressed them in E. coli.  In a variation of this approach we also 
expressed and localized Braun’s lipoprotein (Lpp) from E. coli (Braun and Rehn, 1969; Braun 
and Wolff, 1970) in B. burgdorferi and determined its subcellular localization.   
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Results 
OspA:mRFP1 fusions that are differentially localized in B. burgdorferi follow the +2 rule in 
E. coli. 
Previous studies using varying lengths of B. burgdorferi OspA fused with mRFP1 indicated 
OspA20:mRFP1 localized to the inner membrane, while OspA28:mRFP1 localized to the outer 
surface (Schulze and Zückert, 2006).  We wished to determine if the same cellular localization 
pattern would be present if we expressed these fusions in E. coli.  Therefore, we transformed 
TOP 10 (HB101) E. coli with B. burgdorferi-E. coli shuttle vectors expressing ospA20:mRFP1, 
ospA28:mRFP1, and ospA28K19D:mRFP1 from the same constitutive flaB promoter.  After 
confirmation of red fluorescence (data not shown) we performed sucrose density gradient 
ultracentrifugation using a modified protocol (Chapter II and (Robichon et al., 2005)).  As 
expected, these lipoprotein fusions followed the +2 rule as OspA28K19D:mRFP1 fractionated with 
the inner membrane and the other two fusion proteins fractionated with the outer membrane (Fig 
6.1, Table 6.1). 
 
Lpp expressed in B. burgdorferi is localized to the inner membrane 
Using the inverse approach to the above, we wished to determine the cellular localization pattern 
of an E. coli lipoprotein using B. burgdorferi as a surrogate host.  Therefore, we amplified the 
lpp gene from E. coli HB101 and placed it under the control the constitutive flaB promoter.  A 
hexahistidine tag was placed at the C-terminus to facilitate detection.  Preparation of whole cell 
lysates from B. burgdorferi strains B313 and B31-e2 (Table 2.2) cells expressing Lpp-His 
yielded a band of ~7.2 kDa that reacted with anti-His tag antibodies and a Ni2+-HRP conjugate.  
Lpp was resistant to proteolysis via treatment of intact cells with proteinase K indicating Lpp is 
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not localized to the surface (Fig. 6.3A).  Surprisingly, when we performed membrane 
fractionations we failed to detect any Lpp associated with the outer membrane vesicle fraction 
(Fig. 6.2B, Table 6.1).  Triton X-114 phase partitioning revealed Lpp-His fractionated with the 
detergent phase, suggesting Lpp is properly lipidated and localized to the periplasm (Fig. 6.3C).   
 
Mutagenesis of Lpp does not influence inner membrane localization in B. burgdorferi 
The peptidoglycan (murien) layer in B. burgdorferi is associated with the inner membrane, rather 
than the outer membrane as is in E. coli (Rosa et al., 2005; Motaleb et al., 2000).  We 
hypothesized Lpp might be bound to peptidoglycan causing Lpp to be sequestered in the inner 
membrane before it has an opportunity to interact with LolCDE.  To test this hypothesis we used 
site directed mutagenesis to delete the C-terminal lysine that covalently binds peptidoglycan and 
designated the mutant LppΔK58-His (Zhang and Wu, 1992; Zhang et al., 1992; Braun and 
Wolff, 1970; Choi et al., 1987). Proteolytic shaving and membrane fractionations revealed no 
difference between Lpp-His and LppΔK58-His (Fig 6.2, Fig. 6.3A and 6.3B center lanes). 
 We have previously noted the importance of the lipoprotein tether in proper 
surface/membrane localization (Schulze and Zückert, 2006; Schulze et al., 2010; Kumru et al., 
2010).  The N-terminus of Lpp has only three amino acids that are disordered (Shu et al., 2000) 
and could function as a tether in B. burgdorferi.  To test the hypothesis that these residues 
influence Lpp localization, we used alanine mutagenesis and domain swapping.  First, we 
replaced the S22S23N24 tri-peptide with alanines and tested their surface and membrane 
localization (Fig 6.2).  The phenotype of LppS22A/S23A/N24A-His was identical to that of the 
Lpp-His and the LppΔK58-His (Fig 6.3A and 6.3B right lanes).  Next, we inserted the N-
terminal KQNV tetrapeptide from OspA upstream of the SSN tripeptide of Lpp (Fig. 6.2).  We 
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reasoned since this tetrapeptide  (with the addition of the lipid modified Cys) was sufficient for 
surface localization of mRFP1 (Schulze and Zückert, 2006) that it might be sufficient for surface 
localization of Lpp-His.  However, addition of this tetrapeptide to the N-terminus of Lpp, 
resulted in a null phenotype, i.e., no protein was detected by western blotting using the Ni2+-HRP 
conjugate or anti-His tag antibodies.  Additionally, the protein band corresponding to Lpp-His 
was not detected on coomassie blue stained SDS-PAGE gels (data not shown).   
 
Discussion 
Lipoprotein sorting rules are well established in E. coli and other enterobacteriaceae (Robichon 
et al., 2005; Narita and Tokuda, 2007; Lewenza et al., 2006).  Yet, B. burgdorferi does not 
adhere to these sorting rules (Schulze and Zückert, 2006; Schulze et al., 2010; Kumru et al., 
2010).  The question has been raised if lipoproteins expressed in surrogate hosts follow the 
sorting rules of said host.  This study shows expression of lipoproteins themselves is not 
sufficient to correctly localize them in surrogate hosts.  Although the overall conclusions of this 
study are not surprising, the observation that Lpp expressed in B. burgdorferi localized to the 
inner membrane is intriguing.  We were unsure that the B. burgdorferi lipid modification and 
signal peptidase II enzymes properly processed Lpp, but Triton X-114 phase partitioning clearly 
shows Lpp is associated with the detergent soluble fraction.  This data, taken with the fact that 
the lipobox of B. burgdorferi is more relaxed than E. coli (Haake, 2000; Setubal et al., 2006) and 
thus would be more likely to tolerate substrates from other genera of bacteria, is a good 
indication Lpp is localized to the inner membrane.   
Deletion of Lys 58, which abrogates the covalent linkage to peptidoglycan (Zhang and 
Wu, 1992), has no effect on localization of Lpp in B. burgdorferi.  These results suggest 
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localization is not a consequence of Lpp being bound to peptidoglycan.  We cannot fully rule out 
the possibility that the His tag at the C-terminus in causing a localization artifact or in 
complementing the K58 mutation in peptidoglycan binding.  However, there are two lines of 
evidence that suggest this is not the case.  Previous studies have shown the amino acid 
substitution K58R abolishes the ability of Lpp to bind peptidoglycan (Yakushi et al., 1997; 
Zhang and Wu, 1992), suggesting covalent linkage to peptidoglycan is specific for lysine.  
Second, addition of a FLAG tag to the C-terminus of Lpp does not impact localization of Lpp 
nor the ability to bind peptidoglycan, indicating Lpp with a non-native C-terminus is still 
physiologically functional (Cowles et al., 2011).   
 The +2, +3 and +4 residues of Lpp are disordered and thus could function as the Lpp 
‘tether’ in B. burgdorferi.  Alanine mutagenesis of these residues did not affect localization 
within the envelope.  A possible explanation is the three amino acid tether is too short to be 
recognized by the B. burgdorferi lipoprotein sorting machinery and a longer tether is necessary.  
Borrelia lipoproteins have tethers ranging from 12-46 residues, although only portions of these 
tethers seem to be necessary for proper localization to the surface (Schulze and Zückert, 2006; 
Schulze et al., 2010; Kumru et al., 2010) (Chapter III/IV).   
 Recently, the question was raised if lipoproteins by themselves are sufficient to determine 
localization.  Until now, limited experimental data was available to disprove this hypothesis.  
This study shows lipoproteins expressed in surrogate hosts follow said host’s lipoprotein sorting 
rules.  B. burgdorferi lipoprotein fusions to mRFP1 expressed in E. coli were localized according 
to the +2 rule, while Lpp was localized to the inner membrane in  B. burgdorferi independent of 
the +2 rule.  The data presented here suggests Lpp is localized to the inner membrane according 
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to the imprecisely defined lipoprotein sorting rules of B. burgdorferi.  Further characterization of 
this phenomenon might help in elucidating lipoprotein sorting rules in B. burgdorferi. 
 
 
 
Table 6.1.  Cross genus localization of Lpp and OspA:mRFP1.  
Lipoprotein     E. coli   B. burgdorferi     
Lpp-His    OM, periplasm IM, periplasm    
OspA20:mRFP1   OM, periplasm IM, periplasm 
OspA28:mRFP1   OM, periplasm OM, surface 
OspA28K19D:mRFP1   IM, periplasm  OM, periplasm 
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Figure 6.1. Localization of OspA-mRFP1 fusions in E. coli.   
Membranes were separated by sucrose density gradient ultracentrifugation.  Each fraction was 
collected and analyzed by SDS-PAGE and western immunoblotting using antibodies against 
mRFP1.   (A) OspA28:mRFP1 was localized to the outer membrane, while OspA28K19D:mRFP1 
was retained in the inner membrane.  (B) OspA20:mRFP1, which is inner membrane localized in 
B. burgdorferi, is localized to the E. coli outer membrane.   
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Figure 6.2.  Peptide sequences of Lpp mutants used in this study.  
 Signal peptide, tether residues and His tag sequences are marked.  The +1 Cys residue is marked 
with an arrowhead and the C-terminal Lys that binds peptidoglycan is indicated in red.  The 
mutated residues are shaded in blue. 
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Figure 6.3.  Localization of Lpp in B. burgdorferi.  
(A) Proteinase K (pK) accessibility western blots of Lpp-His, ΔK58, and the S22A/S23A/N24A 
tether mutant.  OspC was used as a protease susceptible, surface control.  FlaB was used as a 
periplasmic, protease-resistant control.   
(B) Membrane fractionation western blots of proteinase K-resistant, i.e., periplasmic Lpp-His, 
ΔK58, and the S22A/S23A/N24A tether mutant. OppAIV served as IM control, while OspC 
served as the outer membrane control.  OM, outer membrane vesicle fraction; PC, protoplasmic 
cylinder fraction (also containing intact cells; (Schulze and Zückert, 2006; Skare et al., 1995). 
(C) Whole B. burgdorferi cells expressing Lpp-His were subjected to Triton X-114 phase 
partitioning, detergent (DT) and aqueous (AQ) phases were analyzed by SDS-PAGE and western 
blotting using Ni2+-HRP specific for the His tag and OspC as a detergent phase control.   
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Chapter VII.  
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Considering the data presented in (Schulze and Zückert, 2006; Schulze et al., 2010), B. 
burgdorferi does not seem to sort lipoproteins based on amino acid identity.  Further, the results 
of the FACS based screen argue against any biophysical properties of the amino acids 
themselves in being permissive for surface localization.  Aromatic and bulky residues tended to 
cluster with the class of mutants that are completely sensitive to proteinase K treatment.  This 
data suggest aromatic and bulky residues may compromise the overall fold of the OspA:mRFP1 
fusion protein, leading to surface localization (Chapter II).  The screen identified two Gly 
residues in these positions were not permissive for surface localization, while two Ala residues 
were permissive (Schulze and Zückert, 2006).  This phenomenon has been observed in OspA 
(Schulze et. al. 2010) and OspC (Chapter IV).  Therefore, we feel it is compelling that a certain 
limited degree of flexibility in this region is required that is afforded by alanine, but not glycine.  
Glycines are unrestricted in their backbone rotational freedom and may introduce excessive 
entropy, which could affect protein folding and protein-protein interactions (Chakrabartty et al., 
1991; Brady and Sharp, 1997; Schulze et al., 2010) 
The screen also identified several amino acid combinations that localized the 
OspA:mRFP1 mutants to the periplasm in lieu of the Asp-Glu residues, but none that could 
retain the reporter in the inner membrane to the same degree (Chapter III).  To our surprise, 
substitution of a Pro in the +2 position of Vsp1 caused complete retention in the inner 
membrane, a phenomenon yet to be observed in Borrelia (Chapter IV).  This finding was 
reminiscent of a study by Seydel et al. where Pro, Trp, Phe, Gly, and Tyr could also act as 
LolCDE avoidance signals in the +2 position of E. coli lipoproteins (Seydel et al., 1999).  Yet, 
these amino acids are never present in the +2 position of native lipoproteins.  In B. burgdorferi, 
Cys, His, Pro, and Trp are never found in the +2 position of native lipoproteins, with His, Trp, 
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and Cys rarely found in the tether (with the exception of the +1 Cys) (Schulze et al., 2010).  
Interestingly, proline is frequently found throughout lipoprotein tethers and has the property to 
disrupt secondary structure and is commonly found as the first residue of a α-helix or β-turn 
(Kabsch and Sander, 1983; MacArthur and Thornton, 1991).  Taken together, these data suggests 
there are different mechanisms of inner membrane retention observed when a Pro is in the +2 
position and placement of two tandem negative charges in certain contexts.  
This work also presented an important expansion to the structurally and functionally 
distinct virulence factors:  OspC in B. burgdorferi and Vsp1 of B. turicatae.  Previously, all our 
data was collected using monomeric OspA.  By investigating surface localization determinants 
of OspC and Vsp1 it enabled us to directly compare and contrast the factors responsible for 
surface localization across different lipoprotein families.  As expected, proper surface display of 
OspC-Vsp1 lipoproteins was dependent on the amino acids in their respective tethers.  A 
phenomenon so far unique to OspC is that two distinct portions of the tether are necessary for 
different steps in surface localization.  Deletion of residues 20-30 results in a defect of flipping 
the lipoprotein across the outer membrane, while deletion of residues 31-41 significantly impairs 
release from the inner membrane. Similar mutations made in dimeric lipoproteins Vsp1 (Fig. 3.3) 
and CspA (data not shown) did not produce this phenotype.  Additional evidence, gained from 
localization of Vsp1 N-terminal signal peptide and tether fused to the structurally-confined 
portion of OspC revealed precisely the same residues were responsible for localization of Vsp1 
and Vsp tether-OspC fusion (Chapter IV/data not shown).  This suggests this phenomenon occurs 
independent of the structurally confined portion of OspC.   
What could be the reason for two distinct regions of OspC that are necessary for surface 
localization?  A great deal of heterogeneity exists at the ospC locus, as there are 19 different 
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major groups of ospC based on DNA sequence homology (Wang et al. 1999).  Yet, the tether 
residues are conserved between these groups, with the exception of a few point mutations 
(Kumaran et al. 2001).  Interestingly, there is absolute conservation of peptide sequence from 
residue N31 to N41 across all 19 of these groups (Kumaran et al. 2001; Fig. 4.1).  This 
implicates the importance of maintaining this specific tether peptide sequence during the course 
of evolution.   
Concurrent with preparing this dissertation a study was published further investigating 
the function of OspC during murine infection.  Several truncated OspC proteins were generated, 
but most notably mutations corresponding to tether residues OspCΔ26-30 and OspCΔ26-35 
(Seemanapalli et al., 2010).  Both of these mutants were surface localized, which is consistent 
with our findings (Chapter IV).  The OspCΔ26-30 mutant was of particular interest as, OspCΔ26-30 
takes weeks longer to disseminate to remote tissues (skin and joints) compared to OspCwt.  
However, there were no significant differences between OspCwt and OspCΔ26-30 in terms of ID50 
and spirochetal burden in the skin or joints (Seemanapalli et al., 2010). Seemanapalli et al., 
concluded that deletion of 5 tether amino acids of OspC impairs B. burgdorferi in dissemination 
to remote tissues.  This data suggests the length of the tether may influence the function of OspC, 
perhaps in reduced ligand binding efficiency in vivo.     
Deletion of 11 or 17 tether residues of OspC had a negligible effect on thermodynamic 
stability as measured by CD spectroscopy. These experiments have disproved the hypothesis that 
tether residues are inherently destabilizing in vitro.  Mutation of amino acids in the tether most 
likely abrogates a protein-protein interaction site between a periplasmic chaperone and the 
lipoprotein, rather than retarding protein folding, as is the case with Sec signal peptides (Park et 
al., 1988; Beena et al., 2004). However, it is important to note that the recombinant OspC 
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proteins used in the thermal unfolding experiments were non-lipidated.  It remains possible the 
lipid moiety could sufficiently destabilize the protein and promote interaction with a periplasmic 
chaperone needed for translocation.  Taken together, this data strongly implicates that a 
periplasmic chaperone(s) must be involved in the translocation process and that the tether is most 
likely a site for this protein-protein interaction.  This best explains why no canonical ‘motif’ has 
been identified despite extensive random and site-directed mutagenesis (Chapter III/Chapter IV).   
Characterization of potential chaperones involved in lipoprotein transport is currently 
underway in our laboratory.  We are in the process of developing a Bimolecular Fluorescence 
Complementation (BifC) system using a split mRFP1 (Jach et al., 2006) with the objective of 
identifying lipoprotein-chaperone interactions in vivo.  Preliminary experiments using OspC 
fused to the N and C terminal halves of mRFP1 indicate proper surface display of both 
constructs, although there are still CtpA-dependent cleavage products (data not shown, see 
Chapter V).  If co-expression of both halves of OspC:mRFP1 results in restoration of red 
fluorescence, this system could be used to probe protein-protein interactions between 
lipoproteins and candidate chaperones hypothesized to the involved in the translocation process.  
Mutants of OspC and Vsp1 localized to distinct cellular compartments (Chapter IV) could 
become even more important in determining how the lipoprotein sorting machinery operates and 
to identify the outer membrane translocation machinery required for surface export. 
We also determined the role of dimerization during the translocation process.  All 
experimental evidence supports the notion that dimerization of OspC and Vsp1 can occur in the 
periplasm in mislocalized mutant proteins, but that the wild type lipoproteins are translocated 
through the outer membrane as monomers (Chapter IV).  Considering OspA surface 
translocation requires an unfolded conformation (Schulze et al., 2010), it is reasonable to 
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postulate that OspC and Vsp1 monomers are also translocated across the outer membrane in an 
unfolded conformation.  Further, this data suggests the outer membrane lipoprotein ‘flippase’ 
does not tolerate folded substrates. 
Potential genes that code for the outer membrane ‘flippase’ must fulfill certain 
characteristics.  First, the gene is most likely essential.  Therefore, the gene is probably encoded 
on the chromosome since B. burgdorferi can be cured of virtually all plasmids, including cp26 
when the essential genes are complemented elsewhere.  However, even the most highly passaged 
strains contain cp26 and at least one plasmid from the cp32 family (Sadziene et al., 1993; 
Casjens et al., 1997; Jewett et al., 2007).  Though unlikely, the possibility remains components 
of the outer membrane secretion complex could be encoded on these plasmids.  Second, it is 
obvious the protein must be an integral outer membrane protein so it must possess both an N-
terminal signal peptide and transmembrane domains. 
A crude bioinformatic analysis was performed using chromosomal ORFs that did not 
contain a transposon insertion from a sufficiently saturated genome-wide transposon library.  
Genes that did not contain an insertion were assumed to be essential (transposon library 
constructed by Norris et al., unpublished data).  Using the translated sequences of the essential 
genes, probable N-terminal signal peptides were identified using the SignalP prediction 
algorithm (available at http://www.cbs.dtu.dk/services/SignalP).  A membrane prediction 
algorithm was then performed on signal peptide positive sequences using the SPLIT membrane 
protein prediction algorithm (available at http://split.pmfst.hr/split/4/).  Finally, the data was 
analyzed by BLAST and is shown in Table 7.1.  Twenty-five potential genes were identified 
using this approach, most with little homology to other genes and/or with unknown functions.  
The tools are now available to define the roles of each of these gene products by using 
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conditional knockout systems (Whetstine et al., 2009; Gilbert et al., 2007).  We foresee this 
approach to be the most viable and decisive in identification and characterization of the outer 
membrane lipoprotein ‘flippase.’ 
 
 
Table 7.1.  Potential genes that code for the B. burgdorferi outer membrane ‘flippase’ 
 
Gene  Predicted function/BLAST results   
bb0038  predicted lipoprotein, highly conserved 
bb0058  tetratricopeptide repeat domain protein   
bb0155  predicted lipoprotein, highly conserved 
bb0171  predicted lipoprotein, highly conserved 
bb0174  aerotolerance-related exported protein 
bb0192  putative membrane protein 
bb0199  putative membrane protein 
bb0236  tetratricopeptide repeat domain protein 
bb0238  TPR Domain containing protein 
bb0259  lytic transglycosolase 
bb0507  conserved among spirochetes, possible lipoprotein, shares homology with spore germination proteins 
bb0535  conserved among Borrelia species, shares similarity with Plasmodium proteins of unknown function 
bb0539  predicted inner membrane protein 
bb0562  predicted sec-independent protein translocase 
bb0602  chaperonin, putative 
bb0624  putative 27.7 kDa hydrolase 
bb0673  putative OrfX protein 
bb0708  divergent polysaccharide deacetylase superfamily protein 
bb0709  putative periplasmic solute-binding protein 
bb0770  divergent polysaccharide deacetylase superfamily protein 
bb0776  signal peptide protein 
bb0783  membrane-bound protein LytR 
bb0794  conserved hypothetical protein 
bb0838  predicted organic solvent tolerance protein 
bb0843  arginine-ornithine antiporter 
______________________________________________________________________________ 
 
During the course of studying OspC and Vsp1 surface localization we recognized a 
smaller molecular weight variant of both proteins that became even more pronounced upon 
addition of a C-terminal linker and/or epitope tags (Chapter IV/V).  These lower molecular 
weight variants are a result of C-terminal processing by CtpA (Chapter V).  Only a handful of 
CtpA substrates have been identified using proteomics (Östberg et al., 2004), and OspC was not 
among them.  There are three possible reasons why the study by Östberg et al. did not detect any 
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difference in the molecular weight and isoelectric point of OspC in their analysis.  First, Östberg 
et al. used the strain B31-A, which expresses OspC poorly (Chapter V; Kumru and Zückert, 
unpublished observation).  Second, surface OspC is processed by CtpA at significantly higher 
levels when the C-terminus is modified by a linker and/or epitope tags (Chapter V).  Finally, 
wild type OspC must be overexpressed to detect the CtpA dependent band (OspC*) (Fig. 5.2C).   
 Perhaps CtpA targets the C-termini of unfolded outer membrane proteins to initiate an 
envelope stress response?  Such a system is reminiscent of how another periplasmic protease, 
DegS, functions in activation of the envelope stress response via the alternative sigma factor, σE 
in E. coli (Walsh et al., 2003).  DegS recognizes unfolded OMPs by their periplasmically 
exposed C-terminal peptides and initiates a complex signaling cascade that results in 
upregulation of envelope stress response genes (Walsh et al., 2003).  Mislocalization of OspC 
and Vsp1 (or any other lipoprotein with a disordered C-terminus) to the periplasm could result in 
CtpA-dependent recognition of the unfolded C-termini.  The released peptides could then serve 
as substrates in induction of an envelope stress response.  CtpA could function as a periplasmic 
‘quality control’ protein to detect mislocalized surface proteins and cleave C-terminal peptides to 
activate this response.  As stated in Chapter V, a possible reason CtpA fails to recognize 
mislocalized OspA is the C-terminus of OspA is structurally confined in a short α-helix.  The 
data presented in this dissertation implicate a broader function for CtpA as a protease involved in 
envelope biogenesis.   
 This research has revealed several determinants involved in localization of lipoproteins in 
B. burgdorferi.  More research is necessary to identify and characterize the lipoprotein sorting 
machinery.  Also, characterization of the localization requirements for native inner membrane 
lipoproteins (OppAI, OppAII, OppAIV, OppAV, IpLA7) is an important step in determining the 
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native mechanism of inner membrane retention.  Theses experiments, in conjunction with the 
data in this dissertation will be invaluable in understanding lipoprotein sorting and envelope 
biogenesis in B. burgdorferi.  Eventually, this could lead to novel treatments and/or vaccination 
strategies that will be extremely helpful in combating Lyme disease and relapsing fever in the 
years and decades to come.   
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